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Abstract 
Since ethylene was first recognized as a phytohormone, the scope of its profound 
and multi-faceted impact on plant growth and development has been continuously 
growing. In Arabidopsis thaliana the response to ethylene is regulated by a group of five 
receptors (ETR1, ETR2, ERS1, ERS2 and EIN4), which are located in the endoplasmic 
reticulum membrane. Ethylene is bound by the membrane-embedded N-terminal part, 
which is followed by a GAF domain. The remaining C-terminal, cytosolic domains resemble 
the classical bacterial two-component system consisting of a histidine kinase (HK) and in 
some receptors a receiver domain. Constitutive triple response 1 (CTR1), whose kinase 
domain bears most resemblance to the RAF family of Ser/Thr protein kinases, directly 
interacts with the ethylene receptors and thus links signal reception to the intracellular 
signalling pathway. Therefore, this signalling pathway presents the interesting case, 
wherein a two-component signalling system manipulates a MAPKKK and possibly a 
MAPKKK signalling cascade. Still, the question of receptor deactivation by ethylene and 
the ensuing signal transduction to CTR1 remain unanswered. 
A number of constructs comprising domains of the receptors as well as the kinase 
domain of CTR1 were expressed and purified. The dimerization domain (DHp) of ERS1 
could be crystallized and solved by MAD to 1.9 Å resolution. The domain is structurally 
similar to other domains of this family, normally found in bacteria, consisting of a 
homodimer forming a coiled-coil and a four-helix bundle. Different to the previously 
available structures a larger portion of the N-terminal coiled-coil could be determined. 
When the DHp domain structure is compared with other HKs it is most similar to the 
phosphatase-competent state, one of the three activities attributed to HKs. A trans-
phosphorylation mechanism in the dimer is predicted by topological arrangement of the 
structure. In addition SAXS data of the cytoplasmic part of ETR1 was collected and a 
model of the domain architecture is presented, showing their relative location with respect 
to each other. A different location of the receiver domain compared to a recent bacterial 
structure is suggested. 
In addition the three-dimensional structures of the active, tri-phosphorylated and 
the unphosphorylated, inactive kinase domain of CTR1 in complex with staurosporine 
were determined at 3.0 Å and 2.5 Å resolution, respectively. They illustrate the 
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conformational rearrangements that form the basis of activity regulation. The active 
kinase domain forms back-to-back dimers in solution, while the unphosphorylated kinase 
is a monomer. The back-to-back dimer interface is virtually identical to the one found in B-
RAF and a number of mutants were identified interfering with the dimerization and also 
affecting the kinase activity. Furthermore the effects of activation loop phosphorylation on 
the activity were explored. The results strongly suggest another layer of activity regulation 
of CTR1 through dimerization in vivo. Steric restraints further indicate regulation of kinase 
activity across dimers with a 'front-to-front' activation interface, which points to CTR1 
mediated ethylene receptor crosstalk generating a continuous head-to-tail oligomer of 
kinase domains.  
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Zusammenfassung 
Seit der Klassifizierung von Ethylen als Phytohormon ist das Wissen um seine 
weitreichende und facettenreiche Rolle und seinen Einfluss auf eine Vielzahl von 
Entwicklungs- und Wachstumsprozessen von Pflanzen stetig gewachsen. In Arabidopsis 
thaliana wird die Reaktion auf Ethylen durch eine Gruppe von fünf Rezeptoren reguliert 
(ETR1, ETR2, ERS1, ERS2 und EIN4), die im endoplasmatischen Retikulum verankert sind. 
Ethylen wird von der N-terminalen, in die Membran eingebetteten Domäne gebunden 
gefolgt von einer GAF Domäne. Die restlichen C-terminalen Domänen ähneln dem 
klassischen Zweikomponentensystem bestehend aus einer Histidinkinase (HK) und einer 
so genannten Empfängerdomäne die letztere jedoch in nur drei der Rezeptoren. 
Constitutive triple response 1 (CTR1), dessen Kinasedomäne jener der RAF Familie der 
Ser/Thr Kinasen ähnelt, interagiert direkt mit den Ethylenrezeptoren und stellt damit eine 
Verbindung zwischen der Signalerkennung und dem intrazellulären 
Signalübertragungsweg her. Dieser Signalübertragungsweg stellt einen interessanten Fall 
dar, in dem das Zweikomponentensystem eine MAPKKK und möglicherweise eine MAPKKK 
Signalübertragungskaskade kontrolliert. Trotz aller Fortschritte ist der genaue Ablauf der 
Rezeptordeaktivierung und der Übertragung des Signals auf CTR1 nicht bekannt. 
Eine Anzahl von Konstrukten, bestehend aus Domänen der Rezeptoren als auch der 
Kinasedomäne von CTR1 wurde exprimiert und gereinigt. Die Dimerisierungsdomäne 
(DHp) von ERS1 konnte kristallisiert und durch MAD, bis zu einer Auflösung von 1.9 Å, 
gelöst werden. Die Struktur ähnelt bakteriellen Strukturen dieser Domäne mit einem 
Homodimer bestehend aus einem coiled-coil und einem Vier-Helixbündel. Konträr zu 
anderen Strukturen konnte ein größerer Teil der Struktur des N-terminalen coiled-coil 
bestimmt werden. Der Vergleich der ERS1 DHp Domäne mit anderen Histidinkinasen legt 
den Schluss nahe, dass die beobachtete Struktur dem Phosphatase-kompetenten Status 
entspricht, einem von drei Aktivitätszuständen, die im Allgemeinen mit HK verbunden 
werden. Ein trans-Phosphorylierungsmechanismus des Dimers wird durch die Topologie 
der Struktur vorhergesagt. Zusätzlich wurden SAXS Daten der zytoplasmatischen 
Domänen von ETR1 gesammelt. Ein Modell der zytoplasmatischen Domänen wird 
präsentiert, mit deren relativen Positionen zueinander. Im Gegensatz zu einer bakteriellen 
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Struktur befindet sich die Empfängerdomäne an einer anderen, weniger zentralen 
Position. 
Zusätzlich wurden die 3-D Strukturen der aktiven, dreifach phosphorylierten und der 
inaktiven, unphosphorylierten Kinasedomäne von CTR1 jeweils im Komplex mit 
Staurosporine bis zu einer Auflösung von 3.0 Å beziehungsweise 2.5 Å bestimmt. Sie 
veranschaulichen die strukturellen Änderungen, welche die Basis der Aktivitätsregulierung 
bilden. Die aktive Kinase liegt als ´Rücken-an-Rücken´-Dimer in Lösung vor, während die 
unphosphorylierte, inaktive Kinase als Monomer vorliegt. Die Kontaktfläche des ´Rücken-
an-Rücken´-Dimers ist jener von B-Raf sehr ähnlich und mehrere Mutanten wurden 
untersucht, welche die Dimerisierung und zum Teil auch die Aktivität beeinflussen. 
Außerdem wurde der Einfluss der Aktivierungsschleifenphosphorylierung auf die Aktivität 
analysiert. Die Resultate deuten auf ein weiteres Level der Aktivierungsregulation durch 
Dimerisierung in vivo hin. Sterische Einschränkungen deuten auf eine Regulierung 
zwischen den Kinasedimeren über eine aktivierende ´Kopf-an-Kopf´ Interaktionsfläche 
hin, mit deutlichen Hinweisen auf eine, durch CTR1, vermittelte Kommunikation zwischen 
den Ethylenrezeptoren was zur Generierung eines kontinuierlichen Oligomers aus 
Kinasedomänen in einer Kopf-Schwanz-Anordnung führt. 
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Introduction 
Ethylene Signalling 
Ethylene and its effects 
Ethylene is a very simple, organic, 
gaseous molecule with the formula C2H4, 
belonging to the unsaturated hydrocarbons 
due to its double bond (Figure 1). The 
molecule is planar with the angles of the sp2 
hybridized carbon close to the ideal angles.  
Abnormalities in the growth of plants in 
the vicinity of gas lamps were observed in the 
middle of the 19th century, but the causative 
agent was unknown. Leakage of gas was 
shown to be responsible and hydrocarbons 
were detected, but the exact nature of the 
molecule was not discovered until 1886, when Neljubov found that ethylene promotes the 
horizontal growth of etiolated pea seedlings (Neljubov, 1901). Unlike other small volatile 
molecules produced and emitted in small amounts by plants, ethylene was subsequently 
suggested to be a plant phytohormone (Crocker et al., 1935) after it was shown 
previously, that ethylene is indeed also produced by the plants themselves (Gane, 1934). 
Ethylene forms a group together with other phyto-hormones like auxin, gibberelline, 
cytokinine and abscisic acid. Plant or phyto-hormones act already at very low 
concentrations and have a relatively low specificity when compared with hormones found 
in animals. Phyto-hormones regulate growth, cell division or differentiation processes with 
the effect depending on the differentiation state of the cell. Furthermore, the signalling of 
the different hormones in plants is closely connected leading to complex phenotypes. 
The effects of ethylene include promotion of fruit ripening in climacteric fruits, the 
senescence of plants, leaf abscission, influence on the seed germination, flower 
senescence and it plays a role in response to biotic and abiotic stresses to name some 
Figure 1: The plant phytohormone 
ethylene 
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(Abeles et al., 1992). The triple response phenotype of etiolated seedlings treated with 
ethylene - inhibition of the growth of stem and roots, curvature of the apical hook and 
radial swelling of hypocotyl - has been used to screen for defects in the ethylene response. 
These effects support the seedling to push through the soil while protecting its sensitive 
tip. 
The effects of ethylene have been utilized for thousands of years but the underlying 
molecular mechanisms have only now begun to get unraveled. Understanding of ethylene 
biosynthesis, its signal transduction pathway and of the multitude of associated regulatory 
mechanisms has therefore big implications for basic plant sciences as well as agriculture 
and economy. The role of ethylene in the ripening of a number of commercially important 
plants like apples or tomatoes and its role in the senescence and abscission of flowers 
makes it an appealing research target. Ethylene or its precursors are used to induce fruit 
ripening, flowering or to de-green citrus fruits. In other cases ethylene production and its 
signal transduction are blocked by a number of compounds like silver thiosulfate, 
extending the life of flowers, or 1-methylcyclopropane, a competitive ethylene inhibitor, 
slowing down the ripening process and extending the shelf life of fruits. Also genetically 
modified organisms (GMO) have been produced exhibiting strong ethylene insensitivity, for 
example preventing ripening in tomatoes or delaying senescence of flowers in petunia. 
Ethylene synthesis in plants 
The ethylene biosynthesis pathway, also termed the Yang cycle (Yang and Hoffman, 1984) 
(Figure 2), is tightly controlled and starts with the precursor S-adenosyl-L-methionine 
(SAM) which is produced by SAM synthase utilizing methionine (Figure 2(1)). In a second 
step SAM is converted into 1-aminocyclopropane-1-carboxylic acid (ACC) and 5'-
methylthioadeosine (MTA) catalysed by ACC synthase (ACS) (Figure 2(2)). This is also the 
rate limiting step in the ethylene biosynthesis. In Arabidopsis thaliana nine functional ACS 
genes can be found with distinct spatial and temporal expression patterns during 
development (Tsuchisaka and Theologis, 2004) and translation can be induced by a 
number of factors. Furthermore ACS proteins are phosphorylated by MPK6 (Liu and Zhang, 
2004) and probably also by calcium-dependent protein kinases (CDPKs), leading to 
increased stability (Hernández Sebastià et al., 2004). Specific regulation of the ethylene 
biosynthesis genes exists transcriptionally in response to internal and external stimuli 
(Tsuchisaka and Theologis, 2004) including ethylene itself (Liu and Zhang, 2004). Also 
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protein turnover serves as a key regulator of ethylene production in plants (Wang et al., 
2004). Methionine is recycled from MTA allowing for the continuous production of ethylene 
without an increasing need of methionine. In a third step ACC is converted to ethylene 
(Figure 2(3)) and the by-products CO2 and HCN by ACC oxidase in an oxygen dependent 
reaction requiring Fe2+ and ascorbate as cofactor and co-substrate, respectively. ACC is 
transcriptionally regulated. Production of ethylene can go up to 500nl g-1 h-1 (Burg, 1962) 
but ethylene was found to be active at concentrations as low as 0.2 nl l-1 (Binder et al., 
2004a).  
 
Figure 2: Yang cycle and ethylene biosynthesis pathway with the three steps described 
marked 1-3. Modified from commons.wikimedia.org/wiki/File:Yang-cycle.png 
1 
2 
3 
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Ethylene perception and signal transduction 
The ethylene signal transduction pathway has been elucidated mainly by using a 
combination of genetic and molecular analyses to place the members in the pathway. In 
Arabidopsis thaliana ethylene is detected by five integral membrane receptors (Figure 3) 
termed ETR1, ETR2, ERS1, ERS2 and EIN4 all of which form dimers (Schaller et al., 1995). 
All receptors are able to bind ethylene with high-affinity and show similar slow-release 
kinetics for ethylene (O’Malley et al., 2005). Initially the search for LOF mutations of the 
receptors itself remained unsuccessful, which is explained by their redundant nature. 
While gain of function mutations lead to ethylene insensitivity, LOF mutations only display 
an ethylene response phenotype when two or more of the five ethylene receptors are 
mutated simultaneously. 
The receptors mainly insert in the endoplasmic reticulum (ER) membrane (Chen et 
al., 2002). This is possible because ethylene is soluble in both aqueous and lipid 
environments. The ethylene binding occurs in the N-terminal membrane domain for which 
a Cu+-cofactor is needed (Rodríguez et al., 1999), which had been predicted based on the 
metal affinity of compounds that have ethylene-like or ethylene antagonistic activities. The 
binding pocket formed by the N-terminal membrane domains of an ethylene receptor 
dimer accommodates a single Cu+-ion. In ETR1 Cys65 and His69 were shown to be crucial 
for copper association (Rodríguez et al., 1999). The copper ion is provided by RAN1, a 
copper ion transporter probably localized in the same compartment as the receptors. LOF 
mutants of RAN1 also show a strong constitutive ethylene response (Woeste and Kieber, 
2000). While other transition metal ions, such as silver, enable the binding of ethylene 
(Beyer, 1976), they do not support the necessary structural changes and therefore act as 
inhibitors. Other inhibitors commonly used are 1-methylcyclopropene (1-MCP) - a gaseous 
binding site competitor - or aminoethoxyvinylglycine (AVG), which blocks ethylene 
biosynthesis. 
In the absence of ethylene the receptors are in an active signalling state and keep 
the interaction partner CTR1 (Clark et al., 1998) in an active state, leading to the down 
regulation of the ethylene signalling pathway (Figure 3). Binding of ethylene causes 
deactivation of the receptors and subsequently of CTR1. The receptors form disulphide 
linked homodimers, but also larger oligomers through non-covalent interactions between 
different receptors have been reported (Gao et al., 2008) comparable to those found in 
bacterial two-component signalling receptors. This is probably the key to respond 
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adequately to the broad range of ethylene concentrations ranging from 0.2nl l-1 to 1ml l-1 
(Binder et al., 2004a), (Chen and Bleecker, 1995). In these higher order complexes the 
receptors show different affinities for each other and the relative ratio of receptor 
interactions changes upon ethylene treatment. Additionally big complexes (up to 900kDa) 
consisting of individual ethylene receptor dimers and a number of unidentified, non-
receptor proteins were observed in vivo. Again the composition of the multi component 
ERS1 complexes changes in response to ethylene. All domains of the ethylene receptors 
were shown to contribute to this big complex, most of whose members remain to be 
defined (Chen et al., 2010). 
 
Figure 3: Schematic representation of the first part of the ethylene signalling pathway. 
The ethylene receptors are bound to the membrane at their N-terminus through 3-4 
transmembrane helices, followed by the GAF domain, the histidine kinase domain and the 
receiver domain. In the absence of ethylene the N-terminal domain of CTR1, shown in 
GAF EIN2 
CTR1 kinase 
domain 
Proteasome 
Receiver 
domain 
Ethylene 
binding 
domain 
Histidine 
kinase 
domain 
CTR1 N-
terminal 
domain 
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dark blue, binds to the HKD and the receiver domain. Active ethylene receptors do not 
interact with EIN2 also being membrane bound, which is prone to proteasome degradation 
(shown in red).  
The next member of the signal transduction pathway is constitutive triple response 1 
(CTR1), the prime downstream interaction partner of the ethylene receptors, which also 
localizes to the ER through interaction with the receptors (Gao et al., 2003) (Figure 3). 
Mutation of CTR1 proved to be particular valuable, as it was the first constitutive ethylene 
response phenotype and also allowed other members of the pathway to be placed through 
double mutants. CTR1 is active in the absence of ethylene and is, like the ethylene 
receptors, deactivated in its presence. The localization of CTR1 to the ER through the 
interaction with the receptors and its active Ser/Thr kinase domain are crucial for its 
function in the pathway. Ethylene binding to the receptor leads to the deactivation of 
CTR1, possibly through a conformational rearrangement or its dissociation from the 
receptors. The interaction occurs between the C-terminal cytosolic part of the receptors 
and the N-terminal part of CTR1, which exhibits no similarity to other domains and whose 
only known function is to bind to ethylene receptors. The influence of the N-terminal 
domain on the activity of CTR1, as found in RAF, is unclear as both the absence (Huang et 
al., 2003) and the presence of regulation (Yanagisawa et al., 2003) by the N-terminal 
domain are reported. Interaction between the two domains of CTR1 has been reported 
(Larsen and Cancel, 2003). The C-terminal domain of CTR1 is most similar to the kinase 
domain of B-RAF. Unlike canonical MAPK pathways, active CTR1 acts as a negative 
regulator of its pathway. MKK9 and MPK6/3 were suggested as the associated MAPKK and 
MAPK of CTR1, respectively (Yoo et al., 2008). Constitutively active MKK9 leads to EIN3 
(discussed later) mediated activation of transcription and was found to be localized to the 
nucleus as is MPK6, which can also be found in the cytoplasm (Yoo et al, 2008).  
CTR1 is also regulated by the phosphatase PP2A-C and shows auto phosphorylation 
activity although the exact sites have not been described (Huang et al., 2003). CTR1 has 
also been connected with other plant hormone pathways as auxin, gibberellin or glucose 
response (Yanagisawa et al., 2003).  
For the B-RAF kinase, with 35% sequence similarity to CTR1, catalytic function and 
activation are dependent on a specific mode of dimerization of kinase domains 
(Rajakulendran et al., 2009). Homodimerization of B-RAF and heterodimers with the 
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pseudo kinase Ksr were observed and even kinase dead B-RAF was able to activate the 
other functional B-RAF molecules through dimerization. Mutations promoting dimerization 
act as activators (Rajakulendran et al., 2009). The Ser/Thr kinase PknB from 
Mycobacterium tuberculosis exhibits a dimerization mechanism mediated by the kinase 
domain, which is able to activate the kinase through an allosteric mechanism even in its 
unphosphorylated state (Lombana et al., 2010). In both cases the interactions are 
mediated by a number of conserved residues in the interface and mutations of these 
residues prevent dimerization. The monomeric mutants of PknB show changes in the 
position of helix C, breaking of the conserved Lys-Glu ion pair, a change of the DFG motif 
position and alterations of the metal coordination found in the active conformation. In 
total the monomer seems to be structurally more flexible than the dimer (Lombana et al., 
2010). So far no similar mechanism has been described for CTR1. 
CTR1, the first downstream target of the ethylene receptors, binds phosphatidic acid 
(PA), an intermediate in lipid biosynthesis, through its kinase domain, which completely 
inhibits kinase activity (Testerink et al., 2007). Additionally the interaction between the N 
and C-terminal domain of CTR1 and the interaction with the ethylene receptors are 
affected by PA (Testerink et al., 2007). In plants PA is produced in response to osmotic 
stress or wounding and could induce an early ethylene pathway response providing an 
explanation how the ethylene pathway is initially activated.  
 
EIN2 is an integral membrane protein with 12 predicted transmembrane helices in 
the N-terminal domain, showing similarity to the Nramp family of cation transports (about 
30% identity in the N-terminus). EIN2 was shown to locate to the ER through the N-
terminal domain and to interact specifically with ETR1 through its C-terminus (Bisson et 
al., 2009), (Bisson and Groth, 2010) which protects EIN2 from degradation by the 
proteasome (Figure 3). Overexpression of the C-terminal domain in light grown plants 
leads to an ethylene response. The precise role of the N-terminal domain has not been 
defined so far. EIN2 seems to play a critical role in the signalling, as the LOF mutations 
show the strongest constitutive ethylene response observed. EIN2 function is also 
connected with a number of other pathways, such as ABA and auxin, possibly helping to 
integrate a number of signals. Despite its key role in ethylene signalling the knowledge of 
this part of the pathway and the mode of signalling on a molecular level is still limited.  
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EIN3 acts downstream of EIN2 and is the founding member of a family of six 
proteins, the EIN3 like (EIL) proteins. Little is known about the role of EIL2 to EIL5 yet the 
various EIL proteins seem to have at least partially overlapping functions (Chao et al., 
1997). These proteins are transcription factors and are found in the nucleus (Chao et al., 
1997), acting as a positive regulator of the pathway and start a transcriptional cascade. 
Signals from the CTR1 initiated MAPK pathway and also from EIN2 converge on the EIN3 
and EIL1 transcription factors, which seem to mediate most of the responses. LOF 
mutants of EIL1 and EIN3 nearly completely abolish the ethylene response in etiolated 
seedlings (Alonso et al., 2003). Overexpression of EIN3 leads to a constitutive ethylene 
response (Solano et al, 1998). The EILs bind as homodimers to the primary ethylene 
response element (PERE) promoter.  
The PERE is found in the promoter region of genes encoding ethylene response 
element binding proteins (EREBPs), which are transcription factors themselves. EREBPs 
can bind to the specific promoters of ethylene inducible genes through the GCC box, an 
element which can be found regulating several defence related genes. The best studied 
member is ethylene response element binding factor 1 (ERF1) (Ohme-Takagi and Shinshi, 
1995). The expression of the ERF1 gene is rapidly induced by treatment with ethylene 
(Solano et al., 1998). 
ERF1 overexpression not only affects pathogen associated genes but leads also to a 
partial triple response (Solano et al., 1998). Other factors seem to play a role in the 
activation of the ethylene response and while some members of the ERF family were 
found to act as activators others function as repressors. Furthermore, some contain GCC 
boxes in their promoter and thereby are regulated by other members of the family. 
Eventually this leads to the transcriptional regulation of hundreds of genes. 
 
The growth related responses to ethylene can be split into two phases, with a first 
rapid but transient phase, which is EIN3 and EIL1 independent, reaching its plateau of 
growth inhibition in etiolated seedlings after 30 min. The second phase leads to a 
sustained and stronger growth inhibition and depends on the two transcription factors and 
is less sensitive to ethylene than the first phase. Here the new, low steady-state growth 
rate is reached after another 30 min. EIN2 is required for both phases, but no information 
on the cellular process controlling the first phase is available (Binder et al., 2004a). The 
first phase responds to ethylene levels as low as 0.2nl L-1. This is much lower than the Kd 
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found for ETR1 expressed in yeast, suggesting a signal amplification process comparable 
to the one found in the two-component system in bacteria (Thomason et al., 2002). The 
second phase needs at least 0.5 µl L-1 of ethylene for a long term effect. This can be 
interpreted as an adaptive system as also found in bacteria. An initial response can only be 
sustained by a higher ethylene concentration or the system will return to the pre-
treatment growth rate. 
An additional way of signal transduction is starting to get dissected in detail, 
exhibiting a mode of signal transduction more similar to the one found in the bacterial 
two-component system (See page 21 for more detailed description). The Arabidopsis 
response regulator 2 (ARR2) was already shown to contribute to cytokinin signalling 
(Hwang and Sheen, 2001), acting as a transcription factor. ARR2 has an N-terminal 
receiver domain and was found to act as a transcription factor for ERF1 (Hass et al., 
2004). This activity and the protein stability depend on phosphorylation of Asp80 in the 
receiver domain. The receiver domain interacts with the histidine phosphotransfer protein 
AHP1 and AHP2 (Hass et al., 2004). They themselves were shown to interact with ETR1 
(Scharein et al., 2008), which possess histidine kinase activity, probably acting as shuttling 
proteins for the phosphoryl group (histidine containing phosphotransfer protein). 
Mimicking phosphorylation of Asp80 in ARR2 causes a triple response phenotype in plants.  
Effects of ethylene on gene expression and protein stability 
Ethylene promotes its own biosynthesis through MPK6, which was shown to 
phosphorylate and stabilize ACC2/6 (Liu and Zhang, 2004). MPK6 itself is part of the CTR1 
initiated MAPK cascade and furthermore gets activated by a number of stress stimuli like 
wounding, drought or extreme temperature providing a link to ethylene signalling. 
Ethylene seems to have different effects on the receptor protein levels themselves. 
Some ethylene receptors in plants were shown to be degraded in response to ethylene 
(Kevany et al., 2007), which could be a way to regulate the response or might also be 
necessary to supply unbound receptors due to the long half-life time (12hr) of ethylene 
binding to the receptors (Schaller et al., 1995). Two receptors from A. thaliana, ERS1 and 
ERS2, show elevated expression when ethylene is present, while ETR2 is degraded if 
ethylene levels are too high (Gao et al., 2008). The receptor protein level correlates with 
the rate of transcription and the up-regulation of the remaining receptors in LOF mutants 
is not able to functionally compensate the missing receptor (O’Malley et al., 2005). 
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Activated MPK3 or MPK6 can phosphorylate EIN3 in vitro at position Thr174 which 
stabilizes EIN3. A second phosphorylation site, Thr592 has a diametric effect promoting the 
degradation of EIN3 (Yoo et al., 2008). CTR1 is not found in the nucleus; thereby the 
phosphorylation of EIN3 at Thr592 cannot be carried out by CTR1 and must function via an 
unknown kinase (Yoo et al., 2008).  
EIN3 is regulated on the protein level and gets ubiquitinated in the absence of 
ethylene by SCF E3 complexes containing the two F-box proteins, EBF1 and EBF2, 
triggering degradation by the 26S proteasome (Guo and Ecker, 2003) (Qiao et al., 2009) 
(Potuschak et al., 2003). EIN3 activates the EBF2 promoter (Konishi and Yanagisawa, 
2008). EBF1 and EBF2 influence the ethylene response at all stages from repression in the 
absence and attenuating the signal in the presence of ethylene to a fast recovery following 
the exposure having temporally distinct roles (Binder et al., 2007).  
As EIN3, EIN2 is degraded by the proteasome in the absence of ethylene. Again two 
F-box proteins, ETP1 and ETP2 were shown to interact with the C-terminus of EIN2 and 
target it for degradation. The levels of ETP1 and ETP2 are down regulated in response to 
ethylene (Qiao et al., 2009). The interaction of ETR1 with EIN2 is dependent on the 
phosphorylation state of the receptor. A reduction of autophosphorylation activity, as 
mediated through ethylene, increases the affinity for EIN2, allowing the HK domain to bind 
to EIN2 (Bisson and Groth, 2010). This interaction protects EIN2 from the degradation by 
the proteasome. 
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2 component system 
The ethylene receptors are similar in sequence to the histidine kinases and their 
receiver domain of the bacterial two-component system. Eukaryotic proteins with 
homology to the bacterial histidine kinases have been identified in fungi and plants 
(Swanson et al., 1994). Two-component systems comprise of a sensor histidine kinase 
(HK) and its cognate response regulator. They are utilized by bacteria to couple 
environmental stimuli with adaptive responses regulating a wide variety of behaviours. Up 
to one hundred TCSs can exist in parallel in bacteria being very specific for the cognate 
partner. Sensor HKs consist in most cases of an extracellular, N-terminal input domain, 
tailored at the specific signal, followed by a transmembrane domain and a cytoplasmic 
kinase domain. The actual HK domain can be subdivided into a DHp domain or 
dimerization domain, containing the conserved histidine residue for phosphorylation 
followed by the catalytic and ATP binding (CA) domain (Figure 5A). The CA domain is 
connected with the DHp domain by a flexible linker and does not contribute to the dimer 
interface.  
Two component system HKs autophosphorylate a conserved histidine residue in the 
dimerization domain often in response to an environmental stimulus. The 
phosphoramidate bond present at the histidine is much less stable than the phosphoester 
bond of hydroxyl kinases. This high-energy phosphoryl group is subsequently transferred 
to a conserved aspartic acid in a receiver domain, which is part of the response regulator 
(RR) (Stock et al., 2000). This leads to a conformational change, which activates the 
output domain of the response regulator, in most instances a transcription factor. The 
phosphotransfer mechanism is sometimes expanded to by phosphorelay mechanism 
involving three steps of transfer of the phosphate moiety, involving multiple proteins 
(Figure 5B). Such a mechanism is found in approximately 25% of all prokaryotic HKs. 
There the HK domain is fused to a receiver domain to form a hybrid kinase. The receiver 
domain accepts the phosphoryl group from the histidine in the DHp domain and transfers 
it to histidine containing phosphotransfer protein (HPt), which eventually transfers it to a 
second receiver domain fused to the output domain. On top of the autophosphorylation 
the HK often possess RR phosphatase activity controlling the level of phosphorylation in 
the receiver domain and thereby the length and strength of the response. The 
phosphatase activity is located in the DHp domain (Zhu et al., 2000). It is influenced in its 
activity through the interaction with the CA domain of the kinase. While a covalently linked 
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CA domain was shown to boost the phosphatase activity, the isolated DHp domain alone 
shows reduced activity in EnvZ (Zhu et al., 2000). 
The receiver domain is also characterized by a number of conserved residues. Two 
acidic residues (Asp616, Glu617 numbering for ETR1) and the phosphoryl accepting Asp659 
form an acidic pocket, binding together with a backbone carbonyl group and two water 
molecules, a divalent cation (Bourret, 2010), often being Mg2+. Lys714 points to this pocket 
helping to coordinate the phosphoryl during phosphorylation and is important for 
phosphorylation mediated conformational changes in the β5α5 loop, forming a salt bridge 
with one of the phosphoryl group oxygens. The cation also interacts with the phosphoryl 
group as well as a highly conserved Ser/Thr (Ser692), which causes the movement of the 
β4α4 loop. Again this aspartyl-phosphate is relatively unstable, especially at a low pH. The 
receiver domain has been proposed to catalyse its own de-phosphorylation often 
stimulated by other proteins (Bourret, 2010), which is thought to be a similar mechanism 
to phosphorylation involving the same residues and an additional water. Another protein, 
often the cognate HK, stimulates the intrinsic autophosphorylation activity. Residues C-
terminal to the Asp phosphorylation site and the conserved Thr/Ser were shown to 
influence the dephosphorylation rate (Thomas et al., 2008).  
Three functional states can be observed within many HKDs: a phosphatase 
competent state able to remove the phosphate from the cognate receiver domain, a 
kinase-competent state able to phosphorylate the conserved histidine residue in the 
dimerization domain and a phospho-transferase state able to interact with the receiver 
domain and able to transfer the phosphate between the two proteins. These different 
activities were shown to be accompanied by structural changes including also asymmetric 
conformations between the two molecules in the dimer (Albanesi et al., 2009). The 
following states are described based on structures obtained for the cold sensor DesK.  
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Figure 4: Structures of the DesK histidine kinase domain in different activation states. 
The dimerization domains were superimposed. The catalytic domain is shown in all 
pictures darker than the dimerization domain. A H188V mutant in the phosphatase-
competent state B H188E mutant in the autokinase-competent state C H188E mutant in 
the phosphotransferase-competent state. The residue at the position of the conserved 
histidine is shown in sticks. 
For the autokinase-competent state (Figure 4 B) a high internal flexibility was 
described between the two domains in the HKD (Albanesi et al., 2009). A simple rotation 
around a glycine acting as a hinge residue could bring the ATP close to the conserved 
histidine residue. The surfaces of the CA and DHp domains would be in good 
complementarity after the rotation. In the phospho-transferase competent state (Figure 4 
C) the two CA domains in DesK show different conformations, with only one interacting 
with the first helix A1 of the dimerization domain (Albanesi et al., 2009). This CA domain 
of chain A now also interacts with a basic patch in the A1 helix of chain B. Chain B is also 
phosphorylated while chain A is not which is also lacking contacts with the second CA 
domain in DesK. The kink in this helix A1 is increased compared to the autokinase-
competent state, also changing the hydrogen bonds around the conserved histidine 
residue. The phosphatase-competent state (Figure 4 A) has a more rigid conformation 
with increased interactions between the DHp and CA domains. This conformation has been 
observed in a number HKDs like TM0853, KinB or DesK. A longer part of the N-terminal 
coiled-coil is visible, increasing the dimerization interface which also attenuates the 
 
  
A B C 
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observed kink in the A1 helix (Albanesi et al., 2009). In this state the kinase activity is 
reduced. 
Transition between the states is companied by a rotation and shearing of the helices 
in the DHp domain, which abandons the coiled-coil and affects the interaction with the CA 
domain. Therefore a model was suggested with the membrane domain of the protein 
stabilizing the coiled-coil, inhibiting the kinase and activating the phosphatase activity. In 
the case of a signalling event the structural changes would free the CA domain thereby 
activating the kinase. Auto-phosphorylation is expected to cause another structural 
change, allowing for the interaction with the receiver domain.  
Figure 5: Schematic layout of the 2-component system. A The sensor domain receives a 
signal and transmits it to the histidine kinase domain, thereby activating it. A conserved 
histidine residue is phosphorylated and the phosphoryl group is subsequently transferred 
to the receiver domain of its cognate response regulator. This activates the output domain, 
often a transcription factor. B The hybrid kinase with a fused receiver domain shows a 
more complex phosphoryl relay. After autophosphorylation on the conserved histidine the 
phosphoryl group is transferred to the aspartate in the receiver domain, which is 
covalently linked to the HK. From there it is moved to a phosphotransfer protein (HPt), 
which finally transfers it to the response regulator carrying out the response. 
A 
B 
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Structures of prokaryotic two-component system elements 
At present more than 160 structures of two-component proteins in prokaryotes are 
available with about 60 of the HK domain or parts of it and about 100 of the receiver 
domain, allowing predictions of the expected structures in eukaryotes. Most of the 
structures represent isolated domains but recently a few complete histidine kinase 
domains (HKD) (Marina et al., 2005) (Figure 6) and also the complex of a HK with its 
cognate receiver domain became available (Casino et al., 2009). The dimerization domain 
consists of a helical hairpin domain packing with a second DHp domain into a four-helix 
bundle as observed for CheA (Bilwes et al., 1999) or EnvZ (Tomomori et al., 1999). They 
contain a hydrophobic core aligned along the long helix axes. Interestingly depending on 
the kinase the relative angle of the helices to each other in the four-helix bundle can vary. 
The conserved histidine residue is found in the middle of first helix, most of the time 
exposed to the solvent and thereby accessible by the catalytic domain. The DHp stem 
region, including the linker connecting the two helices of the dimerization domain, was 
found to be important for the interaction with the cognate response regulator. When it 
was swapped in EnvZ with the corresponding region of another HK the specificity for the 
response regulator was changed (Skerker et al., 2008). Helix 1 of the DHp domain is 
bound by helix 1 and the 5-5 loop of the phosphorylated receiver domain (Casino et al., 
2009). Prior to the four-helix bundle the N-terminal part of the first helix of each subunit 
form a coiled-coil motif making either a direct connection to the transmembrane section 
of the HK (Singh et al., 1998) or through an additional interposed domain. Structural 
changes in the sensor domain are thought to transmit through the helices, affecting the 
activity with a piston like translation of one helix with respect to the other (Falke and 
Hazelbauer, 2001), a rotation movements of the helices or a combination of them. The 
signal probably reaches the HK domain in the form of a helical rotation and tilting. This 
affects the interaction of the helices in the dimerization domain and the contact with the 
CA domain leading to a change of the catalytic domain position (Albanesi et al., 2009), 
(Casino et al., 2009). 
The CA domain exhibits a mixed / sandwich fold consisting of five  strands and a 
single layer three  helices (Figure 6). The CA domain is part of the ATPase/kinase GHKL 
superfamily (Dutta and Inouye, 2000). The CA domain binds ATP between the ATP lid and 
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the central helix with the substrate binding pocket of the CA domain facing the  helix of 
the DHp domain such that it points to the conserved histidine residue. 
The DHp and the CA domains are connected by a hinge region playing a role in 
regulating the phosphatase activity and mutations in the C-terminal part of helix 2 of the 
DHp domain and the linker only affected the phosphatase but not the kinase activity 
(Hsing et al., 1998). This region shows a number of inter-domain contacts and interacts 
also with the response regulator, especially with two loops changing most upon 
phosphorylation (Casino et al., 2009). Mutations might affect the recognition of the 
phosphorylated response regulator thereby affecting the phosphatase activity. 
So far cis (Casino et al., 2009) and trans (Yang and Inouye, 1991) phosphorylation 
mechanisms were shown for HKs, which seems to be a consequence of the different 
connections between the helices in the DHp domain leading to different connections to 
the CA domain. Also the length of the DHp-CA linker has been proposed to play a role 
(Casino et al., 2010). 
HKs contain a number of conserved motifs termed the H, N, G1, F, G2 and G3 boxes. 
They are all needed to form a functional histidine kinase (Parkinson and Kofoid, 1992). 
The H box contains the site of phosphorylation in the DHp domain, while the other motifs 
are located in the CA domain forming the conserved ATP binding site. The G2 box 
facilitates the flexibility of the ATP lid, being located at its N-terminus after the conserved 
phenylalanine or F box (Marina et al., 2001), the only box which is unique for the HKs in 
the GHKL superfamily. The HKs ATP lid is unusually long compared with other ATP lids in 
the superfamily. It shows variability in conformation and composition as it can contain  
helices and thereby the structures also differ in the amount of solvent exposure of the 
bound ATP (Dutta and Inouye, 2000). The lid is highly mobile in the absence of ATP as 
was observed in the apo structures of CheA and NtrB. The G1 and G3 box contact the 
adenosine moiety, while the N box coordinates the Mg2+ bridging the three phosphates 
(Marina et al., 2001). Although general features can be assigned to the motifs the 
molecular details of the nucleotide binding vary for different HKs.  
A number of prokaryotic receiver domains have been described as CheY or PhoP. 
The receiver domain changes its structure upon phosphorylation leading to different 
contacts with the HK domain and therefore affecting the reaction being carried out. 
Structural details are discussed for the case of the ETR1 receiver domain.  
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Figure 6: Crystal structure of the histidine kinase domain of Thermotoga maritima 
TM0853 (PDB ID: 2C2A). The conserved histidine and the ADP are shown in sticks. In the 
centre the dimerization domain with the histidine is forming a four-helix bundle with the 
two catalytic domains sitting on the side. 
Structures of the ETR1 response regulator  
Structural information from eukaryotic HKs and the associated molecules is scarce. 
The structure of the ETR1 response regulator (Müller-Dieckmann et al., 1999) resembles 
the structures observed in prokaryotes (Bourret, 2010). It forms a globular (/)5 domain 
with a central -sheet packed between two and three helices, respectively (Figure 7). The 
main differences in ETR1 to other receiver domains are found in the loop regions. The 
biggest differences to CheY and NarL are being found in loop 5 (3-3), located right 
after the phosphorylation site Asp57. It makes a 180° turn initiated by a conserved proline. 
In ETR1 this loop is flipped to the other side compared with other response regulators, 
making a rearrangement prior to phosphorylation necessary. This loop is thought to play 
DHp domain 
CA domain 
 
CA domain 
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an important role during intermolecular recognition with the HKD. This loop in the 
structure of the TM0853 kinase with its cognate, phosphorylated receiver domain is 
essential for the contact with the CA domain (Casino et al., 2009). In the structure the 
ETR1 response regulator forms a dimer, an oligomeric state, which was also observed in 
solution (Müller-Dieckmann et al., 1999). The contact is mediated by its C-terminus being 
responsible for the majority of the dimer interface, consisting of 455. The interface 
used for dimerization in ETR1 is used in other receiver domains for the interaction with 
the DNA-binding domain, as the biggest structural changes upon phosphorylation of the 
receiver domain occur here. The 5-5 loop was shown in bacteria to bind to helix 1 of 
the DHp domain and using bacterial structures as models the two receiver domains in 
ETR1 are predicted to be on opposite sides of the dimers, so the biological relevance of 
this dimer is unclear. In NtrC and PhoB dimerization was reported to be phosphorylation 
dependent.  
 
Figure 7: Cartoon representation of the ETR1 response regulator (pdb ID 1DCF). Asp616, 
Glu617, Asp659 and Lys714 shown as sticks 
D659 E617 
D616 
K714 
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Domain organization of the ethylene receptor 
Sequence analysis of the ethylene receptors identifies four to five domains 
depending on the receptor. The first 150 residues comprise an N-terminal membrane 
domain. Here the only two disulphide bridges present in the receptor are located right at 
the N-terminus (residue 4 and 6 for ETR1). The membrane domain is crucial for the 
localization of the ethylene receptors to the ER (Chen et al, 2010). Ethylene binding is 
known to occur in the hydrophobic N-terminal part of the receptor dimer. The required 
copper ion is coordinated by the conserved Cys65 and His69 residues (numbering for ETR1) 
(Rodríguez et al., 1999). The first cytoplasmic domain, a GAF domain, was found to play a 
role in the interaction and communication between different receptors (Gao et al., 2008) 
yet the interaction with other receptors seemed to be reduced in a truncated version 
lacking the HK and receiver domain highlighting their contribution. Apart from this its role 
is unknown. GAF domains, named after some of the proteins it is found in (cGMP-specific 
phosphodiesterases, adenylyl cyclases and FhlA), are normally found in phytochromes and 
cGMP-specific phosphodiesterases. The GAF domain belongs to a big family of small-
molecule binding proteins and exhibits a central anti-parallel -sheet which is sandwiched 
by two -helices. The helices pack together in the homodimer to form a four-helix bundle 
(Levdikov et al., 2006).  
The GAF domain is followed by a HK domain and in three out of the five receptors 
(ETR1, ETR2 and EIN4) a C-terminal receiver domain. Both domains were shown to be 
needed for the interaction with CTR1 (Clark et al., 1998).  
The receptors can be split into two subfamilies with subfamily 1 composed of ETR1 
and ERS1 possessing three transmembrane helices and all conserved residues connected 
with histidine kinase activity. For subfamily 2 four N-terminal transmembrane helices are 
predicted and only some of the conserved residues needed for HK activity are present 
(Hua et al., 1998).  
The central histidine kinase domain can, as found in prokaryotes, be split into the N-
terminal, H box containing DHp domain followed by the catalytic CA domain. The CA 
domain has in case of ETR1 and ERS1 all conserved residues known from prokaryotes to 
be crucial for histidine kinase activity in vitro histidine kinase activity has been 
demonstrated (Moussatche and Klee, 2004). The subfamily 2 members have only some of 
these motifs consistent with the absence of histidine kinase activity in these proteins. 
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Subfamily 2 members and also, under certain conditions, ERS1 display Ser/Thr kinase 
activity despite the sequence similarity to histidine kinases (Moussatche and Klee, 2004). 
Functional roles of the receptors and the domains  
The receptors seem to work synergistically and are not able to replace each other 
functionally. Subfamily 1 plays a predominant role as the double mutant etr1 and ers1 
shows an extremely strong constitutive ethylene response including growth inhibition. The 
gain of function allele etr1-1, representing a constitutively active receptor, leads to a 
dominant ethylene insensitive phenotype (Schaller et al., 1995). Single LOF mutants do 
not show an obvious phenotype and double or triple LOF mutants are needed to yield an 
ethylene response phenotype. Phenotypes of the mutants are dependent on EIN2 (Hall 
and Bleecker, 2003). A limited ethylene response could be detected in the subfamily 1 
double mutant, (Qu et al., 2007) and a triple LOF of the subfamily 2 leads to ethylene 
hypersensitivity highlighting the fact that subfamily 2 has a role in the signalling (Cancel 
and Larsen, 2002).  
The growth inhibition of an etr1-7 ers1-2 double mutant, which still had some ERS1 
transcript detectable could be alleviated by a truncated, dominant mutant etr1-1 (1-349) 
converting other receptors into an ethylene-insensitive conformation, but not in the etr1-7 
ers1-3 mutant lacking any subfamily 1 receptors. The truncated receptor might not be 
able to signal itself but could convert other wild-type subfamily 1, but not subfamily 2, 
receptors to an ethylene-insensitive signalling state (Qu and Schaller, 2004). This strongly 
supports communication between the different receptors, at least within a subfamily. 
HK activity was initially demonstrated not to be important for the function as a 
kinase-dead etr1 mutant was able to restore the growth inhibition exhibited by a subfamily 
1 double mutant (Wang et al., 2003) while receptors from subfamily 2 failed to do so. In 
the etr1 etr2 ein4 mutant a truncated version of ETR1 lacking the receiver domain (1-603) 
needed the histidine kinase domain but not its activity to rescue the triple response 
phenotype, yet it showed hypersensitivity to ethylene, suggesting a role of the receiver 
domain. Furthermore when measuring the growth recovery upon ethylene removal, 
mutants of receptors possessing a receiver domain showed slower recovery while the ers1 
ers2 mutant had no effect on recovery (Binder et al., 2004b) supporting a role of the 
receiver domain. More recently it was shown that a full length ETR1 kinase dead mutant 
could not completely rescue the triple response phenotype (Qu and Schaller, 2004), a 
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result in contrast to other studies. In the etr1 ers1 double mutant the slow recovery was 
rescued by full length ETR1 but not by kinase dead ETR1. Ethylene was shown to control 
the autophosphorylation activity of ETR1 which supports a phosphorelay mechanism 
controlling aspects of ethylene signalling (Voet-van-Vormizeele and Groth, 2008). In 
addition autophosphorylation of ETR1 seems to control the interaction with EIN2. This 
interaction is promoted in the absence of the phosphoryl group. All these observations 
contribute to a complex picture of the ethylene receptors and the different roles the 
domains play, with some having a pivotal role while others are engaged in the control of 
finer details. 
 
Heterodimers and higher order interactions between different receptor homodimer 
were reported. ETR1 was shown to copurify with all other receptors and these interactions 
are recruiting a substantial part of the available ETR1 molecules (Gao et al., 2008). ETR1 
seems to interact preferentially with subfamily 2 receptors. The percentage of interaction 
with the other receptors changed upon ethylene treatment. These interactions could allow 
an ethylene insensitive mutant to amplify its signal keeping other receptors in the active 
state.  
Serine/threonine protein kinases 
Ser/Thr kinases play a role in virtually all signalling pathways in eukaryotes, for 
example in response to extra- and intracellular messengers, metabolism, immune defence 
or growth regulation, all requiring a tight and multi-layered control (Schenk and Snaar-
Jagalska, 1999). In their activated state, protein kinases transfer the gamma phosphoryl 
of ATP onto the hydroxyl moiety of their target protein leading to conformational changes 
or change of affinities, which affect their activity. Defining the phosphorylation target 
through the surrounding sequence, Ser/Thr kinases often exhibit a relatively low 
specificity enabling them to phosphorylate whole protein families. Specificity therefore 
also depends on docking or scaffolding interactions (Bhattacharyya et al., 2006). 
Ser/Thr kinases often function in a network of phosphorylation events as found in 
the MAPK signalling pathway with one phosphorylation triggering another one. MAPKKK 
phosphorylates MAPKK which in turn phosphorylates MAPK thereby transmitting the 
activation like in the classical mammalian RAF1 – MEK11/2 – ERK1/2 network.  
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Figure 8: Inactive structure of the RAF-1 kinase domain (pdb ID: 3C4C) bound to the 
inhibitor PLX4720 (omitted). The conserved Lys and Glu in the N-lobe are shown in sticks, 
-strands shown in blue and helices in gold. The activation loop is disordered. 
The protein kinase domains are typically 250-300 amino acids in size adopting a 
common core structure, which can be subdivided into a smaller N-terminal lobe and a 
bigger C-terminal lobe (Figure 8). A cleft between the two lobes contains the binding site 
for ATP utilizing a hydrophobic pocket formed by the N-lobe which helps orienting the 
nucleotide. The C-lobe is responsible for the substrate binding and the initiation of the 
phosphotransfer. The N-lobe consists of an antiparallel -sheet made of five -strands and 
one to three helices, including on prominent termed helix C, while the C-lobe consists 
mainly of  helices. The lobes are connected by a loop forming the back side of the ATP 
binding pocket.  
N-lobe 
C-lobe 
C 
N 
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Numerous kinase structures are available in their active and inactive conformation, 
with or without nucleotide or inhibitor bound. They have revealed a multitude of ways in 
which kinase activity is controlled. There are, however, several hallmark features, which 
can unambiguously be associated with the active and inactive states of the kinase. Those 
features should be regarded as necessary, but not always sufficient conditions of activity, 
because many kinases can display a continuum of activity in between their inactive and 
most active state. Going from a completely inactive to a more active state requires 
structural rearrangements which normally include changes of the position of helix C, a 
change of the DFG position and the structure of the activation loop (Nolen et al., 2004). 
Latter is frequently, but not always, phosphorylated at one or several positions in the 
active state of a kinase leading to a more structured conformation. Once activated the 
kinase toggles between an open and closed conformation while moving through the 
catalytic cycle (Taylor and Kornev, 2011). The hallmark features, conserved among the 
kinase family, can help defining the state of the kinase. One of the most important 
features of an active kinase is the highly conserved Lys72-Glu91 pair found in the N-lobe 
(PKA numbering used in this section, pdb ID: 2CPK) which helps to orient the Lys72. It can 
be observed forming a salt bridge. In active kinases the lysine is positioned to interact 
with the  and  phosphates of the ATP, thereby orientating it. Helix C in the N-lobe, 
including the conserved Glu91 residue, changes its position upon activation, helping the 
Lys-Glu salt bridge to form. A number of different arrangements of the helix C have been 
observed. While the C-terminus of the helix does not change too much in inactive kinases 
the N-terminus moves away from the C-lobe a movement which can also include a 
rotation (De Bondt et al., 1993). The interaction with the activation loop is often linked 
with the out position of the conserved DFG motif which couples, together with the Lys-Glu 
interaction, the conformation of the helix to nucleotide binding (Huse and Kuriyan, 2002). 
The highly conserved DFG motif is located at the beginning of the activation loop in 
the C-lobe. The aspartate residue in the motif interacts with the three phosphates of the 
nucleotide, utilizing magnesium. The correct orientation of Phe185 is thought to position 
the aspartate residue in the DFG motif and to support the inward movement of the helix 
C. In some kinases the phenylalanine of the same motif changes its position between the 
DFG-in (inactive) and –out (active) position. The phenylalanine is part of a hydrophobic 
spine in the active state (also including Tyr164, Leu106 and Leu95 in PKA). These residues 
form a hydrophobic stack connecting the core of the C-lobe to the N-lobe (Kornev et al., 
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2006). It was suggested that this stack helps coordinate the movement of the lobes when 
going through the catalytic cycle. Yet the movement of the phenylalanine is not a 
precondition of the activation, as in Cdk2 or Src inactivation is achieved by a single twist 
of the DFG glycine (Jeffrey et al., 1995). The glycine residue performs a twist upon 
activation, changing its  angle by 140° and forms a hydrogen bond to Asp184 (PKA), 
which turns towards the catalytic site (Kornev et al., 2006). This swing was also 
suggested as a primary event in the deactivation, loosening the surrounding and allowing 
for other changes as the flip of the DFG Phe186. In order to reach the active conformation 
a number of events, caused by the phosphorylation, have been described switching from 
the inactive state, being finally stabilized by a number of hydrogen bonds (Kornev et al., 
2006). 
Positioned in the C-lobe, between the DFG and APE motifs and 20-30 residues in 
length (Figure 9) is the activation loop, playing the pivotal role during activation. The 
activation loop shows great conformational diversity between different kinases. Helix C 
and the activation loop seem to be structurally coupled as a change in one calls for the 
other to change as well.  
The APE motif, which is part of the EF helix, is connected by a loop to the helix F, 
which has been suggested to form a platform on which the activation loop could fold. The 
loop shows no sequence conservation but extensive interactions with the activation loop. 
It changes its position as does the activation loop and may have coevolved with the 
activation loop facilitating its stabilization (Nolen et al., 2004). The P+1 loop is found 
before the APE motif and is named for its contacts with the P+1 residue of the substrate 
just after the phosphorylation site (Knighton et al., 1991). The P+1 loop has the capacity 
to undergo big conformational changes (Pike et al., 2008). Specific for active Ser/Thr 
kinases is a Thr/Ser residue in the P+1 loop, making an interaction with the Lys168 residue 
in the catalytic loop (Figure 9). This conserved threonine also interacts with the aspartate 
in the HRD motif. This interaction has been suggested to help locking the aspartate in the 
conformation needed for the interaction with the hydroxyl of the substrate. 
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Figure 9: Alignment of the CTR1 kinase domain with four human Ser/Thr kinases. The 
activation loop is highlighted in yellow. Highly conserved motifs, crucial for the kinase 
action are shown in red. Residues are coloured in blue according to conservation. 
In the kinase inactive state the activation loop is often found to be disordered or to 
bind to the active site, thereby blocking it as in case of the insulin receptor (Hubbard et 
al., 1994). The activation loop often gets phosphorylated at one or more positions, leading 
to an ordered activation loop and converting the enzyme from the inactive to the active 
state through conformational changes. Upon phosphorylation it adopts a conformation 
allowing for the substrate binding. Kinases requiring phosphorylation for activation have 
an arginine before the conserved catalytic aspartate residue and are therefore termed RD 
kinases (Figure 9). Here a primary phosphorylation site can be defined (Barrett and 
Noble, 2005) whose position is conserved between kinases. This phosphorylation site acts 
by neutralizing a number of positively charged residues, which repel each other in the 
absence of the phosphate group. Normally this basic pocket consists of a basic residue in 
the catalytic loop, one after the DFG motif and an amino acid in the helix C (basic pocket 
His87, Arg165 and Lys189 in PKA, see also Figure 34). The arginine in the HRD motif of 
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Ser/Thr kinases interacts with the phosphoryl group of the primary phosphorylation site, 
supporting the conformation of the activation loop, while in tyrosine kinases the arginine 
forms a cation- pair with a conserved phenylalanine (Krupa et al., 2004). At the 
beginning of the activation loop sits the  strand forming an antiparallel sheet with 
the strand, being connect by three hydrogen bonds, and this sheet is disordered in 
inactive kinases. This sheet is important for the DFG orientation and positioning of helix C 
(Nolen et al., 2004). The attraction of the conserved basic residue after the DFG motif 
(Lys189 in PKA) to the primary phosphorylation site seems to be important for the 
formation of this sheet and to lock the N-terminal anchor of the activation loop. Kinases 
with a basic residue at this position normally require primary site phosphorylation. A 
positively charged residue in the helix C is often found in RD kinases interacting with the 
primary phosphorylation site in the activation loop (Protein kinase B His196, PKA His87). 
Found in all kinases, located in the N-lobe in a turn between -strand 1 and 2, is the 
glycine rich or P loop (Gly-x-Gly-x--Gly,  being usually a tyrosine or phenylalanine, 
Figure 9). It covers and anchors the  and  phosphates of ATP through backbone 
interactions of the glycines, while the aromatic side chain caps the site of phosphate 
transfer. In the C-lobe the catalytic loop with the Ser/Thr kinases consensus motif 
HRDxKxxN is found (Figure 9). The catalytic motif does not seem to be the recipient of 
activating signals as indicated by its relative static position upon activation. The highly 
conserved HRD aspartate Asp166 is responsible for the correct orientation of the 
substrate's phosphorylated hydroxyl side chain and acts as a catalytic base. The histidine 
moiety (tyrosine in some cases), binds to the carbonyl of the DFG aspartate and interacts 
with the DFG phenylalanine being part of the hydrophobic spine linking it to the N-lobe.  
While phosphorylation plays an important role in the activation/deactivation process 
regulatory domains and other domains play also an important role. In RAF the N-terminal 
domain acts as a negative regulator of the C-terminal kinase domain (Stanton et al., 
1989). Src kinase gets inactivated through intramolecular interactions of the kinase with 
the N-terminal SH2 and SH3 domains upon phosphorylation of a tyrosine residue, 
stabilizing the helix C in an inactive conformation (Sicheri et al., 1997). In the cyclin-
dependent kinase Cdk2 helix C helix gets oriented in the active conformation upon binding 
of cyclin (Jeffrey et al., 1995). In CK1 the activation loop is extended allowing for 
additional contacts with the C-lobe stabilizing the loop and making phosphorylation 
unnecessary. 
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Aim of the work 
The comparative simplicity of ethylene receptors, which lack extracellular signal 
binding domains, make them an interesting target for the structural study of signal 
transduction of membrane bound receptors. At the time of the start of this work, the 
structural information of the ethylene signalling pathway was still limited to the response 
regulator of ETR1. While numerous genetic and biochemical results became available over 
the last 10 years, no new structural information was added. A detailed functional 
description of this pathway, made even more interesting through the apparent link of a 
two component system with a MAPK pathway, would significantly contribute to the 
understanding of the initiation of transmembrane signalling and its primary intracellular 
event.  
Therefore, the aim of the project was to gain insights in the cytoplasmic part of the 
receptors, focusing on subfamily 1, and the prime interaction partner CTR1. In the project 
the conditions for the heterologous expression in E. coli and purification of mg amounts of 
the domains and combinations thereof should be developed and based on these results 
structural and where applicable functional studies should be carried out.  
The method of choice is X-ray crystallography and SAXS supported by the local 
access to synchrotron radiation. SAXS should be used to build a low resolution model 
which can be used as a scaffold to place the individual high-resolution domains, if the 
cytoplasmic full length protein fails to crystallize. This could allow assembling a complete 
model of the cytoplasmic ethylene receptor. While structural predictions of domains are 
able to give a first impression of the protein they still miss a lot of details and are in a 
number of cases misleading. Therefore high-resolution structural information is needed to 
verify models obtained from prokaryotic structures in the eukaryotic context and to add 
new, detailed information. 
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Materials and Methods 
Bioinformatics 
Sequences of the proteins (Uniprot identifiers: ETR1: P49333, ETR2: Q0WPQ2, 
ERS1: Q38846, ERS2: P93825, EIN4: Q9ZTP3, CTR1: Q05609, MKK9: Q9FX43) were 
submitted to the Pfam (http://pfam.sanger.ac.uk/) and together with information from the 
literature the domains were assigned. Jpred (www.compbio.dundee.ac.uk/www-jpred/) 
and PSIpred (bioinf.cs.ucl.ac.uk/psipred/) were used for secondary structure prediction. 
Additionally Globplot (www.globplot.embl.de), Disembl (dis.embl.de/) and IUPred 
(iupred.enzim.hu/) were used for the prediction of disordered regions. This information 
together with prior knowledge, comparison with structures available and manual 
inspection of the sequences was used for the design of the constructs. 
The Surface Entropy reduction server (services.mbi.ucla.edu/SER/) (Goldschmidt et 
al., 2007) was used to select residues to be mutated in an attempt to improve the 
crystallizability. 
Construct List  
Table 1: List of all designed constructs and their final status. (GAF cGMP-specific 
phosphodiesterases, adenylyl cyclases and FhlA domain, DHp dimerization and histidine 
phosphotransfer domain, CA catalytic and ATP-binding domain and RD receiver domain) 
Name Protein Start End Domains Status 
H1 ETR1 140 588 GAF and HKD Low expression 
H2 ETR1 140 321 GAF Purified 
H3 ETR1 327 407 DHp Purified 
H4 ETR1 418 588 CA short Low expression 
H5 ETR1 411 588 CA long Purified 
H6 ETR1 327 588 Histidine kinase domain Purified 
H22 ETR1 142 321 GAF domain Purified 
H30 ETR1 327 411 DHp Purified 
H33 ETR1 158 588 GAF + Histidine kinase domain No Expression 
H36 ETR1 308 407 DHp Crystal 
H37 ETR1 158 309 GAF Expression 
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H44 ETR1 308 588 Histidine kinase domain Purified 
H46 ETR1 158 738 GAF + HK + RD Solubility problems 
H47 ETR1 308 738 Histidine kinase domain + RD Purified 
H68 ETR1 308 582 Histidine kinase domain Purified 
H69 ETR1 308 592 Histidine kinase domain Purified 
H70 ETR1 308 596 Histidine kinase domain Purified 
H71 ETR1 308 600 Histidine kinase domain Purified 
H72 ETR1 308 604 Histidine kinase domain Purified 
H78 ETR1 158 407 GAF+ DHp Purified 
H94 ETR1 165 407 GAF + DHp Purified 
H13 ETR2 640 771 Receiver domain Low expression 
H17 ETR2 367 616 Histidine kinase domain No Expression 
H29 ETR2 332 615 Histidine kinase domain No Expression 
H27 ETR2 350 615 Histidine kinase domain No Expression 
H80 ETR2 338 773 Histidine kinase domain + RD No Expression 
H83 ETR2 338 427 DHp Low expression 
H7 ERS1 132 589 GAF and HKD Low expression 
H8 ERS1 132 314 GAF No expression 
H9 ERS1 326 407 DHp Crystal 
H10 ERS1 420 589 CA short Expression 
H11 ERS1 414 589 CA long Expression 
H12 ERS1 326 589 Histidine kinase domain Purified 
H24 ERS1 329 589 Histidine kinase domain Purified 
H34 ERS1 158 589 GAF + Histidine kinase domain No expression 
H35 ERS1 308 407 DHp Structure 
H38 ERS1 158 309 GAF No expression 
H45 ERS1 308 589 Histidine kinase domain Purified 
H73 ERS1 308 586 Histidine kinase domain Purified 
H74 ERS1 308 594 Histidine kinase domain Purified 
H75 ERS1 308 599 Histidine kinase domain Purified 
H76 ERS1 308 604 Histidine kinase domain Purified 
H77 ERS1 308 613 Histidine kinase domain Purified 
H79 ERS1 158 407 GAF + Dhp No Expression 
H93 ERS1 308 407 DHp Purified 
H18 ERS2 382 645 Histidine kinase domain No Expression 
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H28 ERS2 369 579 Histidine kinase domain No Expression 
H14 EIN4 636 766 Receiver domain Purified 
H16 EIN4 367 613 Histidine kinase domain No Expression 
H19 EIN4 642 766 Receiver domain Expression 
H20 EIN4 644 766 Receiver domain Expression 
H21 EIN4 644 761 Receiver domain Expression 
H26 EIN4 350 611 Histidine kinase domain No Expression 
H81 EIN4 339 766 Histidine kinase domain + RD No Expression 
H84 EIN4 339 430 DHp Low expression 
H15 CTR1 540 821 Kinase domain Structure 
H39 CTR1 540 811 Kinase domain Structure 
H41 CTR1 156 408 N terminal domain No Expression 
H43 CTR1 156 811 Full length155 No Expression 
H64 CTR1 1 530 N-terminal domain No Expression 
H65 CTR1 54 530 N-terminal domain No Expression 
H66 CTR1 54 408 N-terminal domain No Expression 
H67 CTR1 1 408 N-terminal domain No Expression 
H82 CTR1 1 821 Full length No Expression 
H88 CTR1 204 409 N-terminal domain No Expression 
H89 CTR1 236 409 N-terminal domain No Expression 
H87 EIN2 478 1270 C-terminal domain Low expression 
H90 MKK9 9 310 Full length Purified 
Table 2: List of all prepared mutants and the obtained result 
Name Protein Based on  Mutation(s) Status 
M10 ETR1 H78 EE177AA No Expression  
M11 ETR1 H78 K271A No mutant 
H52 ETR1 H44 E373T Purified 
H53 ETR1 H44 KK437TT No Expression 
H54 ETR1 H44 KQ476TT Purified 
M1 ERS1 H74 GCG519ACA Purified 
M2 ERS1 H74 H353A Purified 
M3 CTR1 H39 SFGT561AFGA Purified 
M4 CTR1 H39 TFLS704AFLA Structure 
M5 CTR1 H39 T800A Purified 
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M6 CTR1 M4 S710A Purified 
M12 CTR1 M6 T714A Cloned 
M14 CTR1 M6 S703A Purified 
M15 CTR1 H39 S703E Purified 
M16 CTR1 H39 T704E Purified 
M17 CTR1 H39 S707E Purified 
M18 CTR1 H39 S710E Purified 
M19 CTR1 H39 T714E Purified 
M20 CTR1 H39 R604H Purified 
M21 CTR1 H39 F611A Purified 
M22 CTR1 H39 M612W Purified 
M23 CTR1 H39 R604A Purified 
M24 CTR1 M23 R602D Purified 
M25 CTR1 H39 FM611AW Purified 
H40 CTR1 H39 D676N Structure 
H42 CTR1 H15 S561E, T564T, S710E, T800E Structure 
M27 MKK9 H90 D167N Purified 
DNA electrophoresis and purification 
DNA fragments were analysed on an agarose gel. The agarose gel was made by 
dissolving 0.8-1% w/v agarose in 1x TBE buffer and boiling. After cooling to 55°C 
ethidium bromide was added (final concentration of 0.5 µg/ml). The solution was poured 
into a suitable chamber and, after placing a comb, was allowed to cool and set at RT. 
Samples were mixed with a 6x loading buffer (glycerol (30%), 0.25% bromophenol blue) 
and loaded into the slots of the gel. 1x TBE buffer was used as a running buffer. The 100 
bp or 1 kbp Gene Ruler DNA Ladder (Fermentas, St. Leon-Rot) were used for size 
determination. Gels were run at 100 V for 30 min – 1 h depending on the expected size. 
Bands were cut out of the gel and subsequently purified using the QIAquick Gel Extraction 
Kit (Qiagen, Hilden) according to the protocol provided by the manufacturer. 
TBE Buffer 
106 g/l  Tris 
55 g/l Boric acid  
9.3 g/l EDTA pH 8.0 
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SDS PAGE 
In order to separate the proteins by their size SDS-PAGE was used. Normally a 5% 
stacking gel combined with a 12% separating gel was employed. Gels with 10 to 15 slots 
for samples were run in at maximum 120 mA for 1h. Prior to loading the sample was 
mixed with a 4x sample buffer and heated to 95°C for 1min. As a molecular marker the 
ColourPlus Protein marker (NEB, Frankfurt), the ROTI-Mark (Carl Roth Gmbh, Karlsruhe) 
or the PAGE Ruler Unstained protein ladder (Fermentas, St. Leon-Rot) were used. As a 
running TGS buffer (12 g Tris, 57.6 g glycine, 2 g SDS/l) was used. After the run the 
stacking gel was discarded and the running gel was either stained with Coomassie Brilliant 
Blue (0.1% Coomassie R250, 10% glacial acetic acid 400 ml methanol 500 ml ddH2O) or 
the Coomassie blue safe stain. The Coomassie blue safe stain requires the gel to be three 
times rinsed and boiled in water prior to staining, while Coomassie Brilliant Blue needs to 
be destained using 20% methanol, 10% glacial acetic acid in ddH2O. The Coomassie blue 
safe stain is removed after staining and the gel is left in water and does not need to be 
destained. 
PCR 
Primers with the appropriate overhangs for restriction enzyme, LIC (see page 44) or 
PCR cloning (see page 43) were supplied by Biomers (Germany, Ulm). For the PCRs KOD 
Hot Start polymerase (Merck, Darmstadt), Phusion Flash High-Fidelity PCR Master Mix 
(NEB, Frankfurt) or Pfu High-fidelity DNA Polymerase (Promega, Mannheim) were used. 
For colony PCRs Taq Polymerase (NEB, Frankfurt) was used. The PCR reactions were 
carried out according to the respective protocol provided with the polymerase. A typical 
PCR setup and reaction is depicted below. Annealing temperature and the extension 
temperature were adjusted as needed in the specific reaction. When needed a PCR 
Touch-Down protocol was employed were the annealing temperature was dropped by 
2°C for 5 cycles and was continued from this point as usual, keeping the annealing 
temperature of the 5th cycle. 
PCR setup PCR reaction 
0.5 µl  template (typical concentration 50 ng/µl) 1. 95°C 2 min 
5 µl 10x PCR reaction buffer 2. 95°C 30 sec 
2 µl forward primer (10 pmol/µl) 3. 60°C 30 sec 
2 µl reverse primer (10 pmol/µl) 4. 72°C 20 sec/kb 
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5 µl dNTP mixture (2 mM) repeat 2-4 30x 
1 µl Polymerase 5. 72°C 5min 
Add water up to 50 µl 6. 4°C ∞ 
 
For colony PCR reactions one primer specific for the vector and the other primer 
specific for the insert were used. A colony was picked and inoculated in the prepared 
reaction setup and an annealing temperature of 57°C was used. Colonies containing the 
insert of interest were identified by gel electrophoresis of the PCR product.  
Mutagenesis PCR and PCR cloning 
For mutagenesis reactions PfuUltra High-fidelity DNA Polymerase AD (Agilent, 
Waldbronn) was used. Mutagenesis reactions were carried out according to the 
Stratagene Quikchange protocol using 20 cycles per reaction. Non-mutated parental 
plasmid was digested for 90 min at 37°C using DpnI (NEB, Frankfurt) and 1.5 µl were 
used for the subsequent transformation. 
PCR cloning (van den Ent and Löwe, 2006) follows a similar protocol as mutagenesis 
yet instead of the mutagenesis primers an insert containing suitable overhangs to the 
vector was used. The insert was produced in a prior PCR step and gel purified. The 
overhangs anneal with the selected sequences in the vector acting as a mega 
mutagenesis primer. After the extension of the vector now fused with the insert the 
template vector was digested for 90 min at 37°C using DpnI (NEB, Frankfurt) and 1.5 µl 
were used for transformation. 
Plasmid purification 
The plasmid of interest, typically present in the E. coli cloning strains SoloPack® 
Gold Competent (Agilent, Waldbronn) or DH5, was amplified by growing the cells in 5ml 
LB media supplied with the appropriate antibiotic at 37°C with vigorous shaking. After 14-
16 h the cells were harvested by centrifugation and the plasmid was extracted using the 
QIAprep Spin Miniprep Kit (Qiagen, Hilden), as described in the manufacturers protocol. 
Restriction enzyme digestion 
Inserts for the restriction enzyme cloning method were gel purified prior to digestion 
as described and subsequently incubated at the same time with XhoI/NcoI (NEB, 
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Frankfurt) at 37°C for 2 h according to the manufacturer’s protocol. They were purified 
using the QIAquick PCR Purification Kit (Qiagen, Hilden) according to the manufacturer’s 
protocol.  
The vectors were digested following the same protocol as for the insert. They were 
purified by gel electrophoresis as a final step as decribed. 
Ligation 
Ligations were carried out by mixing 1.5 μL 10X Quick ligase buffer, 5 µl of digested 
insert, 2 µl of digested vector, 1.5 µl of T4 DNA ligase (NEB, Frankfurt) and H2O up to 15 
µl. The reaction was incubated at RT for 3h and then heated to 70°C for 5min. An aliquot 
of 3 µl was used for the subsequent transformation step; the rest was stored at -20°C. 
Ligation independent cloning (LIC) 
LIC depends on the vector and the insert having complementary overhangs, which 
anneal in the absence of ligase. To make complementary overhangs with the vector the 
primers needed a 5’ extension, for the forward primer CAGGGCGCCATGgeneofinterest and 
for the reverse primer GACCCGACGCGGTTAgeneofinterest. The vector is cleaved. The 
purified insert and the vector are treated with the T4 polymerase utilizing its 3’->5’ 
exonuclease activity in order to create specific overhangs. The digestion is carried out in 
the presence of a single dNTP species and comes to a halt when the digesting polymerase 
reaches this nucleotide. The polymerase enters there a steady-state equilibrium of adding 
and removing the last nucleotide. Thereby a complementary overhang with a specific 
length is created.  
As a first step 50 µl of vector (1-5 µg of DNA) are cleaved with BsaI as described for 
restriction enzyme cloning. The insert is amplified as described. The purified vector and 
insert are treated with the T4 polymerase 
2 µl 10x NEB buffer 2 
15.9 µl BsaI digested LIC vector or insert 
0.5 µl of the appropriate nucleotide (dTTP for the vector, dATP for the insert)  
1 µl 100 mM DTT 
0.2 µl 100x BSA 
0.4 µl T4 DNA polymerase (3 U/µl) 
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The solution is mixed and incubated at room temperature (RT) for 30 min followed 
by 20 min at 75°C to inactivate the T4 polymerase. The vector and the insert can be 
purified at this step for longer storage. If used soon after the digestion purification is not 
needed. 1 µl of T4 polymerase treated vector was mixed with 2 µl of T4 polymerase 
treated insert. The annealing reaction is incubated at RT for 5 min. 1 µl EDTA (25 mM) is 
added and mixed by stirring gently. Following 5-60 min incubation at RT (exact time does 
not influence result) the reaction mixture is used for transformation as described. 
Transformation 
When doing a transformation following restriction enzyme cloning or ligation 
independent cloning 4 µl of the vector-insert reaction were used. Only 0.5 µl of vector 
were used in case of transformations into expression strains when the vector had been 
prepared beforehand and was at a concentration of about 50 ng/µl. Chemically competent 
cells were thawed on ice and for each reaction 40 µl of cells were used. For cloning either 
SoloPack® Gold Competent (Agilent, Waldbronn) or DH5 cells were used. For protein 
expression transformations were done in BL21(DE3), Rosetta(DE3), Rosetta(DE3) pLys, 
BL21(DE3)  RP, BL21(DE3) RIL or BL21(DE3) chaperone complemented. Cells mixed with 
the vector were incubated on ice for 15 min followed by a heat shock at 42°C for 50 sec. 
Afterwards the cells were cooled on ice for 2 min and 200 µl SOC media was added. The 
cells were incubated for 1 h at 37°C with moderate agitation. Subsequently the mixture 
was plated on pre warmed agar plates containing the appropriate antibiotic and stored at 
37°C overnight. 
Expression 
Freshly transformed cells were used to inoculate 5 ml Luria-Bertani (LB) medium 
(containing the appropriate antibiotic) and were grown overnight at 37°C. The overnight 
cultures were used to inoculate LB, TB (Terrific Broth) or autoinduction medium (Studier, 
2005). They were grown in 2 L baffled flasks at 37°C and 210 rpm to an OD600 between 
0.7 and 0.9 in case of LB and autoinduction medium and up to OD600 of 2 in case of TB 
media. Thereafter the temperature was lowered to 20°C and cells grown in LB or TB 
medium were induced with typically 0.4 mM Isopropyl-β-D-thiogalactopyranosid (IPTG) as 
soon as the lower temperature had been reached. Cultivation was continued for 18 h and 
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the cells were harvested by centrifugation at 5.500 rpm in a JLA-8.1000 rotor for 25 min 
at 4°C. The cell pellets were immediately frozen and stored at -20°C.  
 The DHp domain of ERS1 of ETR1 were expressed using E. coli BL21(DE3) 
cells in 2L of LB media. The cells were grown to an OD600 of 0.6, cooled to 
20°C and induced with 0.4 mM IPTG and harvested after 18 h.  
 The various constructs of the ETR1 histidine kinase domain were expressed in 
E. coli BL21(DE3) cells co-expressing chaperones DnaK, DnaJ, GrpE, ClpB, 
GroEL and GroES (chaperone complement 4, cc4) in 1L of TB media. The cells 
were grown to an OD600 of 1.5, cooled to 20°C and induced with 0.4mM IPTG 
and harvested after 18 h. 
 The various constructs of the ERS1 histidine kinase domain were expressed in 
E. coli BL21 cc4 cells (chaperone complement 4, cc4) in 1 L of TB media. The 
cells were grown to an OD600 of 1.5, cooled to 20°C and induced with 0.4 mM 
IPTG and harvested after 18 h. 
 The full cytoplasmic construct of ETR1 (H46) was expressed in Rosetta cells 
(containing codons rarely used in E. coli) in 2 L of TB media. The cells were 
grown to an OD600 of 1.5, cooled to 20°C and induced with 0.05 mM IPTG and 
harvested after 18 h. 
 The GAF and DHp domains of ETR1 (H78) were expressed in Rosetta cells in 
of media. The cells were grown to an OD600 of 2, cooled to 20°C and induced 
with 0.4 mM IPTG and harvested after 18 h. 
 The kinase domain of CTR1 was expressed in E. coli strain BL21 cc4 cells. The 
overnight cultures were used to inoculate 2 L of autoinduction medium. They 
were grown to an OD600 of between 0.7 and 0.9 after which the temperature 
was lowered to 20°C. Cultivation was continued for 18 h. 
SeMet Expression 
The media for the SeMet labelling was prepared according to the following protocol: 
•    100 ml M9 x 10 (For 1 L: 80 g Na2HPO4, 40 g KH2PO4, 5 g NaCl, 5 g NH4Cl) 
•    10 ml Trace elements solution (100x) (for 1 L 5 g EDTA, 0.83 g FeCl3 x 6 H2O, 
84 mg ZnCl2, 13 mg CuCl2 x 2 H2O, 10 mg CoCl2 x 6 H2O, 10 mg H3BO3, 1.6 mg 
MnCl2 x 6 H2O) 
•    20 ml Glucose 20% (w/v) 
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•    1 ml MgSO4 1M 
•    300 μl CaCl2 1M  
•    1 ml Biotin (1 mg/ml) 
•    1 ml Thiamin (1 mg/ml) 
•    Amino acids mix (40 mg/ml of 19 amino acids except methionine) 
The plasmid was transformed into the methionine auxotroph B834 (DE3) strain. A 50 
ml preculture was prepared with appropriate antibiotics added and grown overnight at 
37°C. 15 ml of the preculture were centrifuged and resuspended in 5 ml of the growth 
media and added to the flask containing 500 ml of the growth media. Subsequently 
seleno-methionine was added under the fume hood to a final concentration of 50 mg/L. 
The flasks were incubated at 37°C at 210 rpm. As soon as the OD600 reached 1.0 the 
temperature was lowered to 27°C and the cells were induced with 0.4 mM IPTG and 
incubation was continued overnight and harvested as described before. 
Cell lysis and NiNTA purification 
The initial lysis buffer and its pH were chosen individually for each protein (Table 3) 
depending on the pI. Later, initial results were refined also taking into account the 
outcomes of Thermofluor (see page 50) and solubility screening. After thawing on ice, cell 
pellets were resuspended in lysis buffer in a final volume of 20 ml per 5 g of cells and 
lysed by pulsed sonication on ice for 2 × 90 s. The specific buffer used for each construct 
can be found in Table 3. The lysates were centrifuged at 19.000 rpm using an SS-34 rotor 
at 4°C for 60 min. The supernatants were filtered through a 0.22 µm membrane. The 
NiNTA column had been stripped using 0.5 M EDTA, washed with water followed by 2 
column volumes (CV) 8 M Urea washed again with water followed by equilibrated against 
100 mM NiSO4 and washed again with 5 CV water. For a preparative purification the 
supernatant was loaded onto a 5 ml Ni-NTA Superflow Cartridge (Qiagen, Hilden) and for 
expression screening 0.5 ml NiNTA in a gravity flow column was used equilibrated against 
buffer A (20 mM buffer, 250 mM NaCl, 5% glycerol and 3 mM -ME). In case of H39 and 
H46 0.1% (w/v) CHAPS was added in the buffer A. The column was washed with four 
column volumes (CV) of buffer A followed by 3 CV of buffer A with 10% buffer B (buffer A 
containing 500 mM imidazole). The proteins were eluted with a gradient of 10-70% buffer 
B in buffer A (50-350 mM imidazole) within 8 CV. Fractions were collected and analysed 
on a SDS PAGE gel. 
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Table 3: Buffer conditions used during purification for different constructs 
Construct Customized lysis buffer for selected constructs 
H35 20 mM Tris pH 8.5, 150 mM NaCl, 5% v/v glycerol, 20 mM Imidazole, 1 mM 
EDTA-free protease inhibitors, 1 mg ml-1 DNAse 
H36 20 mM Tris pH 8.0, 100 mM NaCl, 5% v/v glycerol, 20 mM Imidazole, 1 mM 
EDTA-free protease inhibitors, 1 mg ml-1 DNAse 
H39 20 mM HEPES pH 7.5, 350mM NaCl, 3 mM -ME, 5% v/v glycerol, 0.1% w/v 
CHAPS, 20 mM Imidazole, 1 mM EDTA-free protease inhibitors, 1 mg ml-1 
DNAse 
H46 20 mM Tris pH 8.8, 150 mM NaCl, 1 M Urea, 3 mM -ME, 0.1% w/v CHAPS, 
20 mM Imidazole, 1 mM EDTA-free protease inhibitors, 1 mg ml-1 DNAse 
H47 20 mM Tris pH 8.5, 250 mM NaCl, 0.1% w/v CHAPS, 20 mM Imidazole, 1 
mM EDTA-free protease inhibitors, 1 mg ml-1 DNAse 
H78 20 mM CHES pH 9.0, 250 mM NaCl, 3 mM -ME, 5% v/v glycerol, 0.1% w/v 
CHAPS, 20 mM Imidazole, 1 mM EDTA-free protease inhibitors, 1 mg ml-1 
DNAse 
Dialysis and 2nd NiNTA step 
Dialysis was carried out at 4°C. The buffer was chosen according to the buffer used 
for the NiNTA step. 2 L of 20 mM buffer, 150 mM NaCl and 6 mM-ME were prepared and 
allowed to cool down. The protein was mixed with TEV in a minimum ratio of 1 mg TEV : 
50 mg protein and filled into a rinsed dialysis tube with an appropriate cut-off for the 
protein. The sealed dialysis bag was put into the buffer solution, which was stirred at 100 
rpm and incubated overnight. 
The protein solution in the dialysis tube was collected the next day and passed over 
a NiNTA column equilibrated against the dialysis buffer. The flow-through was collected 
and used for further steps. The flow-through and the elution were analysed using a SDS-
PAGE gel to assess the uncleaved fraction and the remaining contaminations.  
Size-exclusion chromatography 
As a final step of purification size-exclusion chromatography (SEC) was used utilizing 
either a HiLoad 26/60 Superdex 75 or 200 column (Amersham Biosciences) ), depending 
on sample volume. The column was pre-equilibrated in a buffer chosen for each individual 
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construct. The protein was concentrated using a Vivaspin concentrator (Sartorius, 
Göttingen) to less than 5 ml (if possible down to 2 ml) and loaded onto the column. 
Fractions were collected and analysed on a SDS PAGE gel. Fractions containing pure 
protein were pooled and again concentrated using a Vivaspin concentrator. 
Coupled assay 
Activity of the purified CTR1 kinase domain and various mutants was determined 
using a coupled in vitro kinase assay (Cook et al., 1982). The reaction buffer consisted of 
25 mM HEPES pH 7.5, 350 mM NaCl, 1 mM DTT, 10 mM MgCl2, 1% glycerol 1 mM NADH, 
2 mM phosphoenolpyruvate, 2.2 U lactate dehydrogenase, 1.5 U pyruvate kinase and 250 
nM kinase unless indicated otherwise. The reaction was started by the addition of 1 mM 
ATP, which was serially diluted in 100 µl reaction volume at 30°C. The assay was recorded 
over a period of 1 h using the microplate reader Power Wave X Select (BIO-TEK 
Instruments) at a wavelength of 340 nm. The maximum reaction velocity was calculated 
from the slope of the resulting time curve as change in absorbance at 340 nm. The data 
followed simple Michaelis-Menten kinetics, which was applied for the calculation of kinetic 
constants with a nonlinear least-squares best fit of the data (Graphpad Prism5, Graphpad 
Software). 
Kinase-Glo® Luminescent Kinase Assays  
The assay measures the amount of ATP remaining after the kinase reaction. A 
luminescent signal is generated, which correlates with the amount of ATP still present. 
The assay used is linear up to 500 µM ATP. The protein (about 1 mg/ml) is mixed with 
ATP (in the range of 50-300 µM) in a total volume of 20-50 µl in a 96well plate and 
incubated for typically 30 min at RT. The same amount of stabilized luciferase (Ultra-Glo™ 
Luciferase, Promega, Mannheim) is added and the signal is allowed to stabilize for 5min. 
The luminescent signal is measured using an Infinite M1000 (Tecan, Männedorf, CH) and 
compared to the signal obtained of a sample in the absence of enzyme. 
Mass spectroscopy 
Samples were diluted with 0.1% TFA to a final concentration of 1-10 pmol/ µL with 
the optimum being 5pmol. Subsequently 2 µl were mixed with 2 µl of sinapinic acid (10 
mg/ml) and 1 µl was spotted and dried on a plate which was injected into an Applied 
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Biosystems VOYAGER-DE STR workstation MALDI TOF mass spectrometer. 50 spectra 
were acquired and summed up during one measurement. 
Thermofluor assay 
Folded and unfolded proteins can be distinguished through exposure to a 
hydrophobic fluoroprobe. In water and in the absence of a hydrophobic surface the 
fluorescence probe is quenched. If a hydrophobic residue is exposed during the unfolding 
of the protein the quenching is reduced, which leads to a sharp increase of detectable 
fluorescence emission. Unfolding of the protein is induced by a stepwise increase in 
temperature causing an unfolding process. Normally a relatively sharp transition between 
the folded and unfolded states can be observed, where the melting temperature Tm is 
defined as the inflection point of the curve recording the change in fluorescent signal. The 
thermofluor assay is performed in a commercially available real-time PCR instrument 
(MyiQ, Biorad). 94 conditions can be screened simultaneously in order to identify 
stabilizing buffers and ligands (Table 4).  
Typically a protein concentration of about 2 mg/ml, depending on the protein, was 
used in order to achieve sufficient signal strength. If possible 500 µl of protein were 
mixed with 500 µl of water to reduce the effect of the buffer used for purification. If this 
was not possible, due to the instability of the protein in the diluted buffer, 1ml of protein 
at 1 mg/ml was used. 3 µl of 5000x Sypro Orange (Invitrogen, Darmstadt) were added. 
10 µl of this mixture were added to 40 µl of buffer solution already present in the 96-well 
thin-wall PCR plate (Nerbe plus, Winsen). The plate was sealed with an Optic View cover 
seal (Henze Laborbedarf, Elmshorn) and cooled to 4°C for 2 min followed by heating from 
4 to 85°C in increments of 0.5°C for 20sec at each temperature. The wavelengths for 
excitation and emission were 490 and 575 nm, respectively. The customized screen 
consisted of a pH screen from pH 4.5 to pH 10, the anion and cation Hofmeister series, a 
number of nucleotides, different salt and glycerol concentrations and a number of other 
additives reported to stabilize the protein. 
Table 4: List of the 94 buffer conditions used in the thermofluor screen 
Well Buffer Salt Well Buffer Salt 
A1 60 mM Citric acid pH 4.0   E1 2 mM NAD 5 mM MgCl2 
A2 60 mM Na-acetate pH 4.4 
 
E2 2 mM NADH 5 mM MgCl2 
A3 60 mM Na-citrate pH 5.0   E3 2 mM NADP 5 mM MgCl2 
A4 60 mM Na-citrate pH 5.5 
 
E4 100 mM NH4Cl  
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A5 60 mM Bis-Tris pH 6.0   E5 100 mM KCl   
A6 60 mM Sodium phosphate pH 6.0 
 
E6 100 mM NaCl  
A7 60 mM MES pH 6.2    E7 100 mM LiCl   
A8 60 mM Bis-Tris propane pH 6.5 
 
E8 100 mM MgCl2  
A9 60 mM ADA pH 6.5   E9 40 mM CaCl2   
A10 60 mM PIPES pH 6.7 
 
E10 40 mM MnCl2  
A11 60 mM Sodium phosphate pH 7.0   E11 4 mM NiCl2   
A12 60 mM MOPS pH 7.0 
 
E12 10 mM FeCl3  
B1 60 mM Ammonium acetate pH 7.3   F1 40 mM ZnCl2   
B2 60 mM Hepes pH 7.5 
 
F2 100 mM Sodium sulfate  
B3 60 mM Imidazol pH 7.7   F3 100 mM Sodium phosphate   
B4 60 mM Tris-HCl pH 8.0 
 
F4 100 mM Na2-malonate  
B5 60 mM Bicine pH 8.0   F5 100 mM Sodium acetate   
B6 60 mM Tris-HCl pH 8.5 
 
F6 100 mM Sodium formate  
B7 60 mM CHES pH 9.0   F7 100 mM Sodium citrate   
B8 60 mM CHES 9.5 
 
F8 100 mM Na2-tartrate  
B9 60 mM CHES 10.0   F9 100 mM Sodium nitrate   
B10 60 mM Citric acid pH 4.0 250 mM NaCl F10 100 mM Sodium bromide  
B11 60 mM Na-acetate pH 4.5 250 mM NaCl F11 100 mM Sodium iodide   
B12 60 mM Na-citrate pH 5.0 250 mM NaCl F12 100 mM Na-thiocyanate  
C1 60 mM Na-citrate pH 5.5 250 mM NaCl G1 2.5% Glycerol   
C2 60 mM Bis-Tris pH 6.0 250 mM NaCl G2 5% Glycerol  
C3 60 mM Na/K phosphate pH 6.0 250 mM NaCl G3 10% Glycerol   
C4 60 mM MES pH 6.2  250 mM NaCl G4 15% Glycerol  
C5 60 mM Bis-Tris propane pH 6.5 250 mM NaCl G5 20% Glycerol   
C6 60 mM ADA pH 6.5 250 mM NaCl G6 2 mM TCEP  
C7 60 mM PIPES pH 6.7 250 mM NaCl G7 10 mM TCEP   
C8 60 mM Na/K phosphate pH 7.0 250 mM NaCl G8 60 mM NaCl  
C9 60 mM MOPS pH 7.0 250 mM NaCl G9 100 mM NaCl   
C10 60 mM Ammonium acetate pH 7.3 250 mM NaCl G10 150 mM NaCl  
C11 60 mM Hepes pH 7.5 250 mM NaCl G11 200 mM NaCl   
C12 60 mM Imidazol pH 7.7 250 mM NaCl G12 400 mM NaCl  
D1 60 mM Tris-HCl pH 8.0 250 mM NaCl H1 600 mM NaCl   
D2 60 mM Bicine pH 8.0 250 mM NaCl H2 800 mM NaCl  
D3 60 mM Tris-HCl pH 8.5 250 mM NaCl H3 1000 mM NaCl   
D4 60 mM CHES pH 9.0 250 mM NaCl H4 2 mM CHAPS  
D5 60 mM CHES 9.5 250 mM NaCl H5 0.5% octyl-b-D-glucoside   
D6 60 mM CHES 10.0 250 mM NaCl H6 3% D-glucose  
D7 Water   H7 3% sucrose   
D8 2 mM ADP 5 mM MgCl2 H8 30 mM L-Arg 30 mM L-Glu 
D9 2 mM AMP 5 mM MgCl2 H9 5% PEG 1000   
D10 2 mM AMPPcP 5 mM MgCl2 H10 5% PEG 4000  
D11 2 mM dCMP 5 mM MgCl2 H11 Free – own choice  
D12 2 mM dGMP 5 mM MgCl2 H12 Free – own choice  
 
Limited proteolysis 
Limited proteolysis is used to determine domain boundaries or detect exposed loop 
structures. Only protein regions exposed on the surface either present in a loop or in 
unstructured regions are normally subject to proteolytic cleavage. The protein core or 
stable secondary structure elements are usually not accessible for proteases. The reaction 
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conditions are chosen in such a way that mild cleavage is achieved. Small samples are 
taken from the reaction at different time points and analysed via SDS PAGE. The method 
is used to identify stable, well-behaved protein fragments. 
The protein (5 mg/ml) was incubated on ice and mixed with trypsin and 
chymotrypsin at a concentration of 1:200. Samples were taken after 5, 10, 15, 20, 40 and 
60 min and analysed by SDS PAGE. Fragments that were abundant and of reasonable size 
were cut out of the gel and analysed by peptide fingerprinting (Proteomic core facility, 
EMBL Heidelberg) in order to identify the domain boundaries.  
SAXS 
SAXS measurements were carried out at beamline X33 (EMBL/DESY, Hamburg) 
(Roessle et al., 2007) at the DORIS-III storage ring using a Pilatus 1M detector. The 
purified cytosolic domains of ETR1 (construct H46, 64 kDa) was measured at three 
concentrations (3.0, 1.5 and 0.75 mg/ml) in a buffer containing 20 mM Tris pH 8.8, 150 
mM NaCl, 1 mM DTT and 250 mM 3-(1-Pyridinio)-1-propanesulfonate (NDSB). 
Concentrations were determined using either Bradford assay (Biorad, Munich) or by 
refractive index using a Rudolph Research Analytical J357 refractometer, due to the 
interference of NDSB  in UV absorbance measurements. For each measurement eight 15 
sec frames were collected and averaged, using X-rays at λ=1.5 Å and a sample volume of 
50 µl. The measurements were carried out at 8°C using a sample-detector distance of 2.7 
m, covering the momentum transfer range 0.10 nm-1 < s < 5 nm-1 (s = 4π sin(θ)/λ 
where 2θ is the scattering angle). Prior to and following each sample exposure the buffer 
excluding the protein was measured to allow for background subtraction. 
The data were processed using standard procedures, corrected for buffer 
contribution, scaled for solute concentration and extrapolated to infinite dilution using the 
program PRIMUS (Konarev et al., 2003). The radius of gyration Rg and forward scattering 
intensity I(0) were determined using Guinier analysis (Guinier, 1939), assuming that at 
very small angles (s ≤ 1.3/Rg ) the intensity is represented as I(s)=I(0)exp((sRg)2/3). Rg 
and forward scattering I(0) were also determined, along with the  maximum particle 
dimension Dmax using the indirect Fourier transformation approach in the program GNOM 
(Svergun, 1992). The molecular mass (MMSAXS) of the construct was calculated by 
comparison of the interpolated forward scattering with reference BSA samples. The 
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scattering patterns from available high-resolution models were calculated by the program 
CRYSOL (Svergun et al., 1995) in order to obtain the fit of the model to the data. 
 
Ab initio models were reconstructed from the H46 scattering data using the 
simulated annealing program DAMMIF (Franke and Svergun, 2009), which is independent 
of the actual protein concentration. The average of 10 different models, obtained from 
DAMMIF, was used to generate a representative shape envelope, using the program 
DAMAVER (Volkov and Svergun, 2003). The discrepancy of the experimental data was 
calculated as: 
 
where N is the number of experimental points, c is a scaling factor, and Icalc(s) and 
σ(sj) are the calculated intensity and the experimental error at the momentum transfer sj, 
respectively. In addition, the ensemble of ab initio models was used to calculate an 
excluded volume of the particle, VolDAM, which is independent of the estimated protein 
concentrations. Rigid-body models were generated for the all constructs using the 
program CORAL (Petoukhov and Svergun, 2005), where high-resolution models of 
domains are defined as rigid bodies and linkers/loops between the individual subunits are 
represented as random polypeptide chains. 
Crystallization 
The concentration of the protein was determined from the absorption at 280 nm 
using a NanoDrop ND-1000 spectrophotometer and a theoretical absorption coefficient. 
Suitable concentrations for crystallization were estimated using the pre crystallization test 
(Hampton, Aliso Viejo, CA) following the protocol provided. Initial crystallization trials 
were carried out with different 96-well screens from Qiagen or Jena Bio Science at the 
EMBL Hamburg high-throughput crystallization facility (Mueller-Dieckmann, 2006). All 
initial screens were performed using the sitting-drop vapour-diffusion method at 20°C in 
96 well sitting drop low profile plate (Greiner Bio-One, Frickenhausen). Typically 500 nl 
protein solution was mixed with 500 nl reservoir solution and equilibrated against 50 µl 
reservoir solution.  
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Crystals that were suitable for data collection were obtained through customized grid 
screens using 24well hanging drop plates. Additionally the Qiagen Opti-Salts Suite screen 
was employed. Here, the hit solution from the initial screening is mixed 9:1 with 96 
different salts, buffers and other additives and used to search for improved crystallization 
conditions. 
The native crystals of the ERS1 DHp domain were grown in 0.1M tri-sodium citrate 
pH 5.6, 18% (v/v) isopropanol, 18% (w/v) PEG 4000 and 0.32M sodium nitrate. The 
seleno-methionine derivatized crystals were grown in 0.1M tri-sodium citrate pH 5.6, 18% 
(v/v) isopropanol, 18% (w/v) PEG 4000 and 0.22 M thiocyanate. 
Initial crystals of the ETR1 DHp domain were obtained in 0.1M MES pH 6.5 and 15% 
PEG 20000 (w/v) or 0.1 M HEPES pH 7.5, 10% PEG 4000 (w/v)  and 5% Isopropanol. 
Prior to crystallization of the CTR1 kinase domain, AMPPNP with MgSO4 (final 
concentration of 1 mM) or staurosporine (final concentration of 150 mM), a generic 
protein kinase inhibitor, were added to the protein. Crystals of CTR1-kd were obtained at 
20°C in 0.2 M K2SO4 and 15% (w/v) PEG 3350. The best crystals of CTR1-D676N grew 
from 1 M LiCl, 0.1 M citric acid pH 5.0 and 10% (w/v) PEG 6000. 
Crystal freezing and data collection 
Prior to data collection, a single crystal of CTR1-kd or CTR1-D676N was briefly 
immersed in mother liquor augmented with 25% glycerol as a cryoprotectant. Prior to 
data collection, a single crystal of the ERS1 DHp domain was briefly immersed in mother 
liquor augmented with 20% ethyleneglycol as a cryoprotectant. Crystals were mounted on 
CryoLoops™ (Hampton, Aliso Viejo, CA) using a range of loop diameters from 0.05 – 0.5 
mm and were then flash-cooled to -196°C in liquid nitrogen.  
Data processing 
Complete X-ray diffraction data sets of the CTR1 kinase domain crystals were 
collected on beamlines ID23-2 and ID29 at the ESRF, Grenoble, France using a MAR 225 
Mosaic CCD detector and an ADSC Q315R detector, respectively. For CTR1-kd a total of 
170 frames were collected with a rotation range of 1.0°, while for CTR1-D676N a total of 
220 frames were collected with a rotation range of 0.75°.  
Complete X-ray diffraction data sets of the DHp domain crystals were collected on 
beamlines ID23-1 and ID29 at the ESRF, Grenoble, France and at X12 (DESY, Germany) 
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using a MAR 225 Mosaic CCD detector (X12), a Pilatus 6M detector(ID29) and an ADSC 
Q315R detector (ID23-1). For wild type, unlabelled ERS1 DHp domain a total of 1800 
frames were collected with a rotation range of 0.1° at ID-29. For the SeMet crystals a 
total of 140 frames were collected with a rotation range of 1.1° for MAD phasing, while 
for the same crystals a total of 100 frames with a rotation range of 1.0° were collected for 
UVRIP phasing.  
The data were indexed and integrated using XDS (Kabsch, 2010) and were scaled 
with SCALA (Collaborative Computational Project Number 4, 1994). 
Structure determination 
The methodology for the determination of the ERS1 DHp domain SeMet crystals 
using the UV-induced radiation damage method has already been described (Panjikar et 
al., 2011). 
Prior to the methodological UVRIP phasing, MAD data of the same domain were 
scaled using SCALEIT and subjected to HKL2MAP (Pape and Schneider, 2004) using the 
SHELX pipeline running the MAD option. Into the initial map obtained an initial model was 
built with the help of Arp/Warp (Langer et al., 2008). The initial model was refined against 
the native dataset using Refmac 5.6 (Murshudov et al., 1997) and Phenix 1.7 (Adams et 
al., 2010), followed by iterative cycles of manual model rebuilding in Coot (Emsley et al., 
2010). 
The CTR1 kinase domain was solved by molecular replacement using B-RAF (pdb 
ID: 3C4C) as a search model utilizing the program Phaser (McCoy et al., 2007) as 
available through the CCP4 package (Collaborative Computational Project Number 4, 
1994). The initial model was refined against the native dataset using Phenix 1.6.4 (Adams 
et al., 2010), followed by iterative cycles of manual model rebuilding in Coot (Emsley et 
al., 2010). 
Figures of the structures were prepared using Pymol (The PyMOL Molecular Graphics 
System, Version 0.99, Schrödinger, LLC). Figures of the SAXS models were prepared using 
Chimera (Pettersen et al., 2004). Alignments were prepared using MUSCLE (Edgar, 2004) 
and Jalview2 (Waterhouse et al., 2009). 
The atomic coordinates and structure factors for CTR1kd and CTR1D676N were 
deposited at the Protein Data Bank with accession codes 3PPZ and 3P86, respectively. 
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Results 
Bioinformatics and constructs 
The five ethylene receptors were analysed using a number of publicly available 
servers to analyse and define the domains and their borders, which is needed for the 
selection of promising constructs. An overview of all the main constructs and domain 
combinations designed and tested is given in Figure 10, but not all of the individual 
terminal truncations giving similar constructs are shown. Details are listed in table 1.   
Table 1 including the exact start and end position of the constructs. 
 
  
  
 GAF DHp   CA   MD 
ERS2 
 GAF DHp   CA      RD  MD 
ETR1 
 GAF DHp   CA      RD  MD 
ETR2 
 GAF DHp   CA   MD 
ERS1 
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Figure 10: Overview of cloned constructs and their domain organization: MD membrane 
domain, GAF cGMP-specific phosphodiesterases, adenylyl cyclases and FhlA domain, DHp 
dimerization and histidine phosphotransfer domain, CA catalytic and ATP-binding domain 
and RD receiver domain. All constructs are indicated by bars below the schematic 
representations of the proteins, indicating which domain combinations were examined 
therefore not every construct is listed. Red indicates no expression could be obtained, 
orange a low expression level, blue that the protein was purified, yellow crystals and green 
a determined structure  
kinase domain        N-terminal domain 
CTR1 
 GAF DHp   CA      RD  MD 
EIN4 
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ERS1 dimerization domain 
Expression and crystallization 
Initial expression tests of the DHp domain of ERS1 (construct H9) yielded a good 
rate of expression (30mg/l). The protein could be purified to homogeneity using NiNTA 
and SEC, concentrated to more than 20mg/ml and was suitable for crystallization. Initial 
sitting drop crystallization experiments yielded mainly hexagonal crystals in different 
conditions. Unfortunately the crystals only diffracted to 7.5 Å. As a consequence a number 
of different ways were explored to improve the diffraction quality. The His-Tag was 
removed, customized grid screens using 24well hanging drop plates and an additive 
screen using the Qiagen Opti-Salts Suite were employed, different cryo conditions were 
tested, but the diffraction could only be improved to 5 Å using synchrotron radiation. 
Furthermore, the diffraction pattern exhibited a pseudo-dodecagonal symmetry (Figure 
11B). The exact cause of this phenomenon could not be determined, but a possible 
explanation could be alternating layers of a hexagonal symmetry rotated relative to each 
other by 30°. This could also give an indication for the poor diffraction properties of the 
crystals. 
  As the crystals could not be improved the sequence was reanalysed. A new 
construct was designed according to the secondary structure prediction by PSIpred, which 
suggested a different starting point of the first helix. This construct included 18 additional 
residues to the N-terminus (construct H35). The new construct expressed again well and 
was purified using a similar protocol as for the H9 construct. Initial crystallization trials 
yielded again crystals of reasonable size (150 µm x 150 µm x 70 µm). Initial diffraction 
tests showed the benefit of removing the His-Tag when comparing cleaved and uncleaved 
protein. Therefore further trials were carried out using the tag-less construct (H35His). 
Again the crystals were further optimized using the Opti-Salts Suite (Qiagen) and 
customized grid screens and eventually diffracted to 1.9 Å at ID29 (Table 5) in space 
group C2221. The crystals for data collection were grown in 0.1M tri-sodium citrate pH 5.6, 
18% (v/v) isopropanol, 18% (w/v) PEG 4000 and 0.32M sodium nitrate. 
Despite the availability of dimerization domain structures from bacteria (sequence 
identity up to 40%), the attempts to solve the structure using molecular replacement 
failed. This is possibly due to the seemingly continuous stretches of two long -helices 
present in the crystal making it hard to place the model.  
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In general molecular replacement software seems to have problems with this 
domain and/or crystal packing. After solving the structure later by experimental phasing 
in space group C2221 the refined model of the DHp domain in space group C2221 had to 
be modified by removing the first 25 residues for a successful molecular replacement 
search in space group P21212 despite 100% sequence identity and hardly any difference 
in the structures (R.s.m.d. 1.18 Å). 
Phasing 
Phasing by soaking sodium bromide, sodium iodide or 5-amino-2,4,6-
triiodoisophthalic acid (IC3, (Beck et al., 2008)) into the native crystals was attempted. 
Unfortunately, the observed resolution was not optimal for phasing (~5 Å) and data were 
of bad quality due to high mosaicity (>1.3°). Co-crystallization of H35His with 10mM IC3 
yielded crystals, which diffracted to reasonable resolution (3 Å) but no signal of the iodide 
could be observed, probably because the IC3 did not bind in a specific manner. 
As the construct contains seven methionines, labelling with seleno-metheonine was 
carried out. The protein was purified like the native one and yielded crystals diffracting to 
3 Å resolution at X12 (DESY, Hamburg) belonging to space group C2221. The crystals 
were grown in 0.1M tri-sodium citrate pH 5.6, 18% (v/v) isopropanol, 18% (w/v) PEG 
4000 and 0.22M thiocyanate, a similar condition as the native crystal. Following an X-ray 
fluorescence spectrum over the selenium absorption edge, three datasets at the peak, 
inflection and high energy remote energies were collected, all to a similar resolution. Data 
collection statistics for all three datasets are summarized in Table 5. 
The structure was solved using the MAD method, by utilizing the SHELX pipeline as 
implemented in HKL2MAP. The initial map showed clear electron density for helices. The 
model showed the expected features of a DHp domain, namely two long helices forming a 
dimer. The electron density and the data are of good quality (Table 5) and no signs of 
twinning were detected. The Rwork/Rfree of the final model in space group C2221 are 20.4% 
and 24.6%, respectively.  
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Figure 11: A Alignment of the five DHp domains from the A. thaliana ethylene receptors using the program MUSCLE. The linker 
between the two helices in the ERS1 DHp structure is indicated in red. B Initial diffraction pattern of the ERS1 DHp domain showing the 
dodecagonal pattern C Limited proteolysis of the ETR1 histidine kinase domain (Construct H44) 
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Table 5: X-ray data-collection and processing statistics of the ERS1 DHp domain. Values in parentheses are for the highest resolution 
shell. 
  Native SeMet peak SeMet inflection SeMet remote SeMet high res 
X-ray source ID-29, ESRF X12, DESY X12, DESY X12, DESY ID23-1, ESRF 
Wavelength (Å) 0.923 0.9772 0.9777 0.9716 0.9919 
Resolution range (Å) 49.3-1.9 (2.0-1.9) 47.3-3.0 (3.15-3.0) 47.3-3.0 (3.15-3.0) 47.3-3.0 (3.15-3.0) 47 – 2.1 
Temperature (K) 100 100 100 100 100 
Crystal-to-detector distance (mm) 337.13 272 272 272 316.55 
Rotation range per image (°) 0.1 1.1 1.1 1.1 1.0 
Total rotation range (°) 180 154 154 154 100 
Space group C2221 C2221 C2221 C2221 P21212 
Cell dimensions (Å) a = 75.03, b = 98.73,  
c = 77.1  
a = 75.20, b = 99.09,  
c = 77.12  
a = 75.16, b = 99.07,  
c = 77.09  
a = 75.65, b = 99.78,  
c = 77.62  
a = 65.92, b = 69.20,  
c = 108.27  
Observed reflections 151061(24280) 36987(5733) 36764(5768) 37543(5837) 109136 (16951) 
Unique reflections 22944(3593) 11119(1743) 11090(1755) 11339(1827) 27137 (4328) 
Multiplicity 6.58(6.75) 3.3(3.3) 3.3(3.3) 3.3(3.3) 4.0 (3.9) 
Rmerge (%) 5.5(79.9) 7.0(26.0) 7.3(27.5) 5.5(19.6) 5.2 (34.7) 
Rpim (%) 2.5(35.5) 4.6(17.1) 4.8(18.1) 3.6(12.9) 2.8(19.1) 
Completeness (%) 99.4(97.6) 99.8(99.1) 99.9(99.6) 99.7(98.2) 99.2 (99.8) 
<I/ (I)> 14.3(2.5) 17.6(6.1) 16.8(5.4) 22.1(7.9) 17.1 (3.7) 
Wilson B factor (Å
2
) 43.7 43 43 43 38.4 
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Another dataset of the SeMet crystals grown in the same condition as the native 
crystals also diffracted to 2.1 Å at ID23-1. Unexpectedly they belonged to space group 
P21212, in contrast to all other previously collected datasets. The crystals in space group 
C2221 contain two molecules in the ASU crystals with 61.1% solvent content, while in 
space group P21212 four molecules are present in the ASU with 54.5% solvent content. In 
space group P21212 the model could be refined to R-values of 21.4% and 25.5% (Table 
6). When comparing the models they are similar (for chain A: r.m.s.d = 0.99 Å  r.m.s.d = 
0.71 Å when excluding the first 10 residues) with small differences at the N and C-
terminus, mainly in the number of residues with clear electron density. For the further 
analysis of the coiled-coil interface the structure obtained from the crystals in space group 
C2221 was used due the better resolved N-terminus, especially in chain A. 
The structure was also solved with the UVRIP method to demonstrate the general 
applicability of this approach to phasing (Panjikar et al., 2011). The final model was 
similar to the one obtained using the classical approach, therefore validating the 
applicability of this new approach to phasing.  
Table 6: Refinement statistics of ERS1 DHp domain in two different space groups 
Space group C2221 P21212 
Resolution range (Å) 49.3-1.9 (2.0-1.9) 47 – 2.1 
Rwork / Rfree % 20.4/24.6 21.4 / 25.5 
No. atoms   
    Protein 1547 3045 
    Other     - 8 
    Water 93 189 
B-factors   
    Protein 51.2 44.1 
    Water 50.6 43.4 
R.m.s. deviations   
    Bond lengths (Å) 0.014 0.016 
    Bond angles () 1.232 1.495 
Overall structure 
Similar to the DHp domain structure of a sensor histidine kinase from T. maritima 
(pdb ID: 2C2A), the ERS1 DHp domain consists of two anti-parallel helices connected by a 
short hairpin loop. It forms a dimer, which coils around a central supercoil axis, such that 
the N-termini are adjacent (Figure 12). The first helix, helix A, in the molecule (307-371, 
with no observable electron density for the first four residues in chain B) extends for about 
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90 Å from the N-terminus to the hairpin. Helix A has a pronounced kink, which divides the 
helix in two parts (A1 and A2). A short hairpin linker (372-376) connects helix A to helix B, 
which is shorter, with a length of about 40 Å and one to two residues at the C-termini of 
the different chains not being visible. A proline residue, five residues C-terminal of the 
phosphorylatable histidine, found in the majority of histidine kinases is located just after 
the kink in helix A. One helix in each dimer has a stronger kink compared to the other 
helix in the dimer. When superimposing the structure from the conserved histidine residue 
to the end (residues 353-404, r.m.s.d.=0.44Å) the bending of helix A1 in chain B is 9° 
larger than in chain A. Helix A1 contains the conserved phosphoryl-accepting residue 
His353, which is exposed on the surface and assumes different side chain orientations 
between the different chains. Helix A2 makes contacts with helices B and B' in the dimer 
and vice-versa. 
Dimer interface 
 The first 42 residues of the helices A1 and A1' form a parallel coiled-coil (Figure 13) 
and engage in a left handed twist of about 23°. At the end of the coiled-coil the helices 
move apart and at the C-terminus helix A2 and helix B together with A2’ and B’ form a 
Figure 12: Structure of the ERS1 DHp domain in cartoon representation. The two 
conserved phospho-receiving histidines are shown as sticks; waters are shown as yellow 
spheres. Sections of the helices are labeled as referred to in the text. 
N 
C 
Helix A1 Helix A2 
Helix B 
Four-helix bundle Coiled-coil 
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four-helix bundle with a left-handed twist of about 23°- 28°. This angle and also the anti-
parallel topology are favoured by four-helix bundles (Chou et al., 1988). A similar topology 
is found in the sensor histidine kinase from T. maritima, which is different from the 
unusual, more parallel topology found in EnvZ (pdb ID: 1JOY). In the dimer there is a 
large interface, burying 2120 Å2 of solvent accessible surface area from each molecule as 
calculated by PISA. This creates a large energy barrier for dissociation of the dimers. The 
majority (62%) of the interface is contributed by the four-helix bundle (1310 Å2) yet the 
contribution of the coiled-coil interface (810 Å2) is more than in other DHp domains. This 
is due to the fact that a larger portion of the coiled-coil could be observed than in any 
other structure reported so far.  
 In general histidine kinases possess coiled-coils with heptads not easily recognized by 
standard detection algorithms but can be detected by more specialized software (Singh et 
al., 1998). Compared to the canonical heptade (a-g) repeat normally observed, with apolar 
or hydrophobic residues at position a and d they frequently have charged residues at 
heptade positions a and d as found for example in EnvZ or Sln1 (Tao et al., 2002). They 
are predicted to destabilize the coil mediated interactions (Tripet et al., 2000). Still in the 
yeast osmosensor Sln1, which also possess a coiled-coil made up of helix A1, the coiled-
coil was found to be important for the dimerization and the kinase activity (Tao et al., 
2002), while the four-helix bundle alone could not maintain the dimer. 
Only some of the ERS1 heptade agree with the classical model. The coiled-coil is stabilized 
by three leucine residues pointing to the core (Leu313, Leu323 and Leu330), hydrogen bonds 
formed by the two Ser316 side chains and in addition a salt bridge network (Gln326, Asn327) 
(Figure 13). Similar networks of polar residues within the core of the coiled-coil at heptade 
positions a and d can be also be found in other structures for example in HIP1 (pdb ID 
3I00), tropomyosin (pdb ID 2EFR) or GIT1 (pdb ID 2W6A). Two arginine residues, Arg320 
and Arg334, normally not typically found at position a or d, contribute to the core with the 
aliphatic straight chain being buried in the centre. The guanidinium groups are pointing 
away from each other, being exposed to the solvent.  
The linker connecting the two helices of the dimerization domain in the close packed 
hydrophobic core of the four-helix bundle is, with the exception of a few side-chains, 
relatively rigid, as judged from the low B-factors. Apart from Leu374 pointing to the 
hydrophobic core of the four-helix bundle it consists of polar residues. As shown by the B-
factors the coiled-coil seems to be more flexible than the four-helix bundle.  
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The asymmetric unit of space group P21212 contains four molecules forming two 
dimers. The two dimers are oriented in an anti-parallel orientation, with contacts between 
the two four-helix bundles. From previous studies, the formation of a dimer was expected. 
Interestingly the DHp domain eluted from the gel filtration column at about 55 kDa 
consistent with a tetramer given the tagged monomer of 14 kDa. Analysis using the PISA 
web service predictes the dimer as well as the tetramer to be stable in solution. Previously 
also higher-order non-covalent interactions have been observed (Gao et al., 2008). 
Therefore interactions between the receptors are expected to some degree and dimers 
could help assemble these clusters. Yet, when expressed together with the catalytic 
domain only a dimer could be observed. This questions the biological significance of the 
tetramer observed, also as the concentrations used during gel filtration and crystallization 
are not the physiological ones and steric clashes with the other domains, omitted in this 
construct, would occur. In addition the interaction between the two dimers occurs in an 
anti-parallel fashion, with the N-termini pointing in different directions. This argues against 
Figure 13: N-terminal coiled-coil of the DHp domain. Side chains involved in the 
interface are shown as sticks; hydrogen bonds are shown as yellow dashed lines and 
waters as yellow spheres.    
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this interaction to occur in vivo as the receptors are inserted into the membrane at the N-
terminus, which would require the N-termini to point in the same direction.  
ERS1 homodimer 
When superimposing the dimerization domains of ERS1 and TM0853 (Casino et al., 
2009), different topologies of the helical hairpins become apparent (Figure 15), with a 
counter-clockwise connectivity in ERS1. TM0853 exhibits the less frequently observed cis-
phosphorylation mechanism when transferring the -phosphate of ATP to the conserved 
histidine residue. In TM0853 the helical hairpin domains are connected the opposite way 
compared to DHp from ERS1. The superimposition of the helices in the DHp domain of 
TM0853 and ERS1 allows for the modelling of a complete ERS1 HK. In this model the 
catalytic domain from one molecule in the dimer comes close the histidine residue in the 
other molecule. This indicates a trans-phosphorylation mechanism for ERS1 (Yang and 
Inouye, 1991) as frequently observed in histidine kinases. 
 In order to examine the inferred mode of action in ERS1, based on the comparison 
with TM0853, the dimerization domain construct (H35) was modified in order to obtain a 
completely untagged version. Untagged DHp was then co-expressed with full length 
histidine kinase domain (H74), which carried a His-tag. Purification via NiNTA, proteolytic 
removal of the tag and subsequent SEC resulted in the purification of homodimeric full-
Figure 14: SDS gel and SEC chromatogram of ERS1 HKD co-purified with its DHp 
domain 
First peak  Second peak 
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length HK and the heterodimer of HK and DHp (Figure 14). Using the size difference 
between the two constructs in the heterodimer this can be used to discriminate between 
cis- and trans-phosphorylation. 
 
Figure 15: Superimposition of the ERS1 DHp domain (blue) onto the corresponding 
domain from TM0853 (green) from T. maritima with helices shown as cylinders for clarity. 
The receiver domains in complex with TM0853 were omitted, ADP bound to the TM0853 
CA domain is shown as sticks. A zoom on the hairpin connecting the loops is shown on the 
right. 
ETR1 dimerization domain 
The initial construct (H3) of the ETR1 DHp domain expressed very well yielding 
approximately 20mg/L of protein. Yet the construct was unstable and could not be stored 
even at 4°C having the tendency to precipitate. Different buffer compositions were tested 
but were not successful in stabilizing the protein.  
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A new construct, which was extended by four C-terminal residues (H30), was 
prepared but exhibited the same pathologies. Eventually another construct, with similar 
start and end points to the one prepared for the ERS1 DHp domain, was prepared 
extending the N-terminus, which lead to a better behaved protein (H36). It was purified 
similar to the ERS1 DHp domain by NiNTA and SEC and could be concentrated to 
15mg/ml. Initial crystallization trials yielded very fragile and small crystals. The effect of 
the His-tag removal was explored and yielded crystals of improved mechanical stability. 
Initial crystals were obtained in 0.1M MES pH 6.5 and 15% PEG 20000 (w/v) or 0.1M 
HEPES pH 7.5, 10% PEG 4000 (w/v)  and 5% Isopropanol. Initial diffraction experiments 
were unsatisfying due to the poor resolution (7 Å). 
Customized grid screens using 24well hanging drop plates and an additive screen 
using the Qiagen Opti-Salts Suite were employed in order to improve the initial hits. A 
common scheme of the hits could be observed always involving PEG in the range from 
3350 – 20000 Da and HEPES at different pH. The crystals diffracted up to about 3.6 Å but 
had to be cut to 4.25 Å to obtain a satisfying signal to noise ratio of about 2 in the highest 
resolution shell. Even though the DHp domain of ERS1 was used as a search model 
exhibiting 84% sequence identity, no solution could be obtained probably because of the 
poor data quality. The crystals belonged to space group P21212 with a big unit cell 
(a=59.7 Å b=159.7 Å c=173.6 Å ===90°) containing approximately 14 molecules in 
the ASU (assuming 50% solvent content). 
No further attempts to improve were made, also as the structure of the ERS1 DHp 
domain was solved, with the sequence being very similar to the ETR1 dimerization domain 
(Figure 11A). No changes in the overall structure are therefore expected and also the 
topology is anticipated to be similar due to the high similarity of the linker sequence 
between the two helices (Figure 11 A).  
ETR1 and ERS1 histidine kinase domain 
Expression of the ETR1 and ERS1 full length histidine kinase domains was only 
possible in the presence of chaperones (strain BL21 (DE3) cc4). Initial crystallization trials 
of the constructs H6 and H12 in the presence of the ATP analogue AMPPNP did not yield 
any crystals. Limited proteolysis was tested in order to define a more stable construct 
using chymotrypsin and trypsin. While the treatment with trypsin did not yield any 
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obvious predominant band, a new, strong band emerged and remained stable even after 
prolonged digestion following the digestion with chymotrypsin (Figure 11C indicated with 
an arrow). Analysis by peptide mass fingerprinting of the isolated band showed that the 
cleavage occurred within the catalytic domain of the HK, cutting a disordered or exposed 
loop, yielding thereby an unusable fragment. The cut occurs around residue 510-525 (an 
exact position could not be obtained due to the limited resolution of the MALDI-TOF). 
When comparing the sequences of the ethylene receptor histidine kinase domains to 
bacterial histidine kinases an obvious insertion in the catalytic domain can be observed 
ranging approximately from 494 to 507 (ETR1 numbering). Mapping this loop onto the 
structure of a bacterial histidine kinase (pdb ID 2C2A) it appears to be an insertion in the 
loop connecting D with E and as indicated by the limited proteolysis results, probably 
leads to some flexibility in this region. This loop is pointing away from the active site of 
the kinase and one could speculate that it plays a role in the interaction with the receiver 
domain.  
With the information of the favourable N-termini of the DHp domains of ERS1 and 
ETR1 available, a number of variants of the C-terminus were tested yielding constructs 
68-72 in case of ETR1 and 73-77 for ERS1 (Table 1). All expressed equally well and could 
be purified similar to the original constructs. Both domains were found to be active as 
judged using the Kinase-Glo Luciferase Assay. Still no crystals could be obtained when 
attempting to crystallize in the presence of 1mM AMPPNP and 1mM Mn2+ (ETR1) or 1mM 
AMPPNP and 1mM Mg2+ (ERS1). The effect of mutations of lysine or glutamate sitting on 
the surface of the domain and not in a secondary structure element (as predicted by the 
SER server) was tested with three mutants. E373T, KK437TT and KQ476TT were prepared 
and expressed. KK437TT did not yield any expression, while the other two mutants could 
be expressed and purified but did also not lead to any crystals. 
ETR1 cytoplasmic domains 
ETR1 without the membrane domain consisting of the GAF, HK and receiver domain 
(residues 158-738) was initially expressed in BL21 cc4. However, some of the chaperons 
co-purified with the overexpressed ETR1 protein, indicating that some portion of the 
protein was not well folded or had some hydrophobic patches exposed, thereby keeping 
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the chaperone attached. This impurity could not be removed in the course of the 
purification.  
To overcome this problem expression in other strains was tested and reasonable 
expression levels could be obtained in Rosetta cells in combination with a very low 
concentration of IPTG giving the protein more time for folding. NiNTA purification yielded 
relatively pure protein (Figure 16 A), yet it was not very well suited for crystallization, 
albeit being pure (99% as judged by SDS PAGE), as it precipitated during concentration. 
In order to improve the solubility beyond approximately 0.4 mg/ml a number of additives 
were explored. The addition of 0.5 M of 3-(1-Pyridinio)-1-propanesulfonate, belonging to 
the non-detergent sulfo betaines (NDSB), permitted the concentration to at least 2.5 
mg/ml allowing further studies. 
Subsequent trials to explore the necessary concentration range of NDSB needed to 
keep the protein in solution converged at 200-250 mM NDSB. This concentration of NDSB 
was chosen as a compromise to minimize interference with crystallization and other 
biochemical and structural characterization methods, and protein solubility, which declined 
below 150 mM NDSB.  
In order to determine a low resolution model of cytoplasmic portion of ETR1, SAXS 
measurements were carried out at the X33 BioSAXS beamline in Hamburg. Initially the 
impact of NDSB at various concentrations was tested. A linear increase of the background 
scattering was detected with increasing NDSB concentration but did not interfere with 
successful data collection. An upper limit of 500 mM NDSB was estimated as being still 
compatible with SAXS measurements. 250 mM NDSB were used in the subsequent 
measurements in order to reduce the background effects. The SAXS data statistics are 
summarized in table 7.  
 
Table 7: Overall SAXS parameters of the ETR1 cytoplasmic domain 
RgGuinier,  
nm 
RgGNOM,  
nm 
Dmax,  
nm 
I(0) MMSAXS,  
kDa 
MMcalc,  
kDa 
VolSAXS,  
nm3 
VolDAM,  
nm3 
4.7 ± 0.1 4.8 ± 0.1 15.8 ± 
0.5 
28.5 45 ± 5 64.8 282 ± 30 165 ± 20 
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Figure 16: A Gel of fractions of the ETR1 full cytoplasmic part after NiNTA purification B 
Model (see text) build of the ETR1 GAF (red), dimerization (yellow) and CA (blue) 
domains, which was used as a starting point for the SAXS data analysis.  
While measurement of the construct at 20°C led to precipitation, measuring at 8°C 
prevented aggregation. As the strong signal of NDSB at 280 nm interfered with 
concentration determination using the Nanodrop photometer two different methods very 
employed namely determination using the Bradford assay and using an analytical 
refractometer. Unfortunately the results from both methods differed by a factor of 9. While 
the concentration determined by the Bradford assay was 2.5 mg/ml the refractometer 
indicated a concentration of about 20 mg/ml, the latter possibly an artefact of the high 
NDSB concentration. The strength of the SAXS signal of the protein was therefore 
compared with a similar sized protein (BSA) measured at different concentrations and was 
estimated to be about 3mg/ml. SAXS curves were determined at 3, 1.5 and 0.75 mg/ml 
protein concentration (by dilution).  
  
Structure alignment of the ERS1 dimerization domain with the dimerization domain 
of a bacterial histidine kinase from T. maritima in complex with its cognate receiver 
domain (pdb ID 3DGE) or of the uncomplexed HK (pdb ID 2C2A) placed the catalytic 
domains in two different conformations reflecting their different orientations in both 
structures. The residues were mutated in order to match the ETR1 sequence using the 
SCRWL method as implemented (http://ffas.burnham.org/protmod-cgi/qryByAliForm.pl) 
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where all template residues are replaced by target residues, thereby giving a model of the 
full length ETR1 histidine kinase domain. The structure of a cyanobacterial phytochrome 
GAF domain (pdb ID 2K2N) was chosen to represent the ethylene receptor GAF domain. 
Small, overlapping helical sections at the C-terminus and N-terminus, respectively, of 2K2N 
and the dimerization domain were used to link both domains. Since the receiver domain of 
ETR1 is expected to have a different location from the one observed in a bacterial 
structure (pdb ID 3DGE) it was omitted from this model (Figure 16 B) and added later to 
the final SAXS envelope (Figure 17 C). In the bacterial model HKD and receiver domain 
are two different proteins, while they are linked by a 15 residue linker in ETR1. Yet in the 
model from T. maritima there is a gap of about 50 Å between the C-terminus of the HKD 
and the N-terminus of the receiver domain. In order to keep the relative position of the 
two domains as observed in the T. maritima structure the 15 residue linker would have to 
be in a highly extended conformation. For this reason a different location of the receiver 
domain is assumed.  
The model was used for rigid body refinement of SAXS data with short, flexible 
linkers defined between the GAF and dimerization, the dimerization and CA domain. 
Between the CA and receiver domain a 15 residue linker was defined as the only restraint 
for the location of the receiver domain. The model generated fits the data well in the low 
angle range (<1.5 nm-1) but deviates at higher angles where short range and inter-atomic 
distances contribute to the scattering (Figure 17 A and B). Yet the excellent fit to the data 
at low angles allows the description of the global architecture of the dimer with a 
dumbbell shaped structure (Figure 17 A and B red line). This also fits well in the shape 
envelop determined by ab initio modelling using DAMMIF (Franke and Svergun, 2009) 
(Figure 17 A and B red dashed line). In this approach the position of the CA domain in the 
HKD was quite different from those observed in bacterial HKs with a 90-180° rotation 
relative to the dimerization domain. As there is no other evidence for such a rotation the 
model was considered to be at least partially artificial and therefore another approach was 
tested.  
The same models were used (Figure 16 B) and defined as a rigid core. The receiver 
domain was placed relative to this core model by rigid body modelling with a 15 residue 
flexible linker between the CA and receiver domain. Both models with the flexible receiver 
domain fit the SAXS data and the ab initio model equally well (Figure 17 A and B blue and 
green line). The difference between the two models is too small to be determined by 
R e s u l t s  -  P a g e  | 73 
 
SAXS. Again the fit is very good at low angles ((<1.5 nm-1, χ=1.1 for 2C2A and χ=1.13 for 
3DGE) and deviates again at higher angles (χ=2.7 and χ=2.9 for the two different models 
used for rigid body modelling). The data did not show features at higher angles showing 
mainly background scattering. In these cases the position of the CA domain was fixed to 
the position found in bacteria and in the absence of other evidence these models are used 
for the analysis and are more likely to reflect the true architecture. 
In both models (Figure 17 C) the position of the receiver domain is different from the 
one found in the structure of the T. maritima HKD in complex with its cognate receiver 
domain. While in the bacterial structure the receiver domain is placed close to the 
dimerization domain it is placed further away in ETR1, packing again the CA domain on 
the side averted from the ATP binding site. In both cases the active site consisting of 
Asp616, Glu617, Asp659 and Lys702, normally invariant in receiver domains, with the Asp659 
thought to receive the phosphate from the histidine in the dimerization domain, is pointing 
away from the dimerization domain (Figure 17 C central and right pane). For the 
phosphotransfer a 180 degree rotation as well as a small translation would be needed as 
Asp659 and His353 are, depending on the model, 30 – 40 Å apart.   
 
A B 
C 
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Figure 17: A Fit of the different models of the cytoplasmic domains. Dots indicate the 
measured intensity. The calculated scattering for the model obtained by CORAL is shown 
in red, in blue and green the scattering for the constructed models when defined as rigid 
bodies and the red dashed line shows the results obtained from ab initio modelling B 
B A 
C 
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Zoom of the low angle region of A using the same colours C Models of the cytoplasmic 
domains of ETR1 using a rigid core homology model. On the left an overlay of the 
DAMMIF shape envelope with the refined models based on the two different structures, 
each with the receiver domain placed by rigid body modelling with the rest defined as a 
rigid core. In the centre the model based on 2C2A and on the right the model based on 
3DGE. The GAF domain is shown in yellow, the dimerization domain in red, the CA domain 
in blue and the receiver domain in green. 
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ETR1 GAF and GAF & DHp domain 
The initial expression test yielded soluble protein for the GAF and GAF-DHp domains 
of ETR1 but never yielded satisfactory results for the same two domains from ERS1. 
Expression was achieved in the E. coli Rosetta strain. Three different constructs were 
tested comprising the GAF domain and two containing the GAF and DHp domain. 
Especially the latter construct was prone to precipitation, which could be avoided through 
the addition of 5 mM DTT and 1 mM EDTA. A thermofluor screen was used to screen for a 
better buffer and a high pH was found to be beneficial. Subsequent buffers contained 20 
mM CHES pH 9.0, 150 mM NaCl, 5 mM DTT and 1 mM EDTA for SEC. Using this buffer the 
protein was reasonable stable. The oligomeric state was assessed by AUC. As expected 
the GAF domain together with the DHp domain forms a dimer (Figure 18). 
Initial crystallization trials of ETR1 GAF and DHp domains (construct 78) yielded 
spherically shaped crystals. They seemed to be composed of multiple crystals growing 
together. A number of optimization screens and the Qiagen Opti-Salts Suite were 
employed in order to improve the crystals and a few appeared which looked from their 
shape like single crystals, albeit quite small in size. Unfortunately they did not diffract. A 
few crystals, apparently consisting of multiple crystals, were tested. They diffracted x-rays 
to about 5 Å yet it appeared as if multiple lattices were present. Despite several attempts 
the diffraction quality could not be improved to reasonable levels.  
Figure 18: AUC result of the ETR1 GAF and dimerization domain indicates a dimer 
(calculated size of the monomer 28.4 kDa) 
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CTR1 kinase domain 
The C-terminal and catalytically active protein kinase domain of CTR1 (CTR1-kd) 
from A. thaliana was heterologously expressed in E. coli in the presence of chaperones 
and purified via NiNTA and SEC. In addition to the wild type construct, a kinase dead 
variant of CTR1-kd was expressed and purified and characterized both kinetically and 
crystallographically in order to elucidate the mechanisms, which account for the activation 
of CTR1-kd. Both constructs start 18 residues before the first glycine residue of the 
conserved P-loop motif (residue 540 of full length CTR1). The wild-type version extends to 
the natural C-terminus while the inactive kinase lacks the last 10 amino acids, which have 
been found structurally disordered in the wild-type version.  
Heterologously expressed wild type CTR1-kd was purified from E. coli complemented 
with chaperons as a mix of multiply phosphorylated forms. Mass spectrometry indicated 3, 
4, 5 and 6 phosphorylation sites (Figure 21A). Those sites, identified by tandem MS 
(MSMS) peptide fingerprinting, are concentrated within the P-loop motif at Ser561 and 
Thr564 and within the activation loop at Ser703, Thr704, Ser707 and Ser710. The complete 
absence of phosphorylation sites in a, likewise heterologously expressed, kinase dead 
version of CTR1-kd (CTR1-D676N, see below) shows that the identified phosphorylation 
sites are the result of self-directed activity. Attempts to further fractionate the mixture of 
differently phosphorylated CTR1-kd using a MonoQ column failed. This finding is 
consistent with earlier observations, which suggested multiple phosphorylation sites in full 
length CTR1 as well as in its protein kinase domain and the absence of phosphorylation in 
a kinase dead version (Huang et al., 2003). There the samples were expressed in insect 
cells but neither the extent nor the locations of the phosphorylation sites were given.  
The initial storage buffer (Tris pH 8.5, 150 mM NaCl, 1 mM DTT, 1 mM MgCl2 and 1% 
glycerol) was found to be unsuitable for the protein and a thermofluor screen was 
employed to improve the long-term sample stability. HEPES pH 7.5 and an elevated NaCl 
concentration (350 mM) were found to be beneficial for protein stability and were 
subsequently used. 
Initial crystallization trials yielded no crystals in the presence of 1mM AMPPNP. The 
stabilizing effect of a number of ligands was assessed using a thermofluor screen. The 
addition of staurosporine gave the strongest improvement in terms of thermostability of 
about 21°C (Figure 19). The addition of the broad range kinase inhibitor staurosporine, 
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albeit at a very low concentration of 100 µM (approximately 4x the protein concentration), 
yielded in the initial screen small crystals in a number of conditions.  
Supported by kinetic data, the structures therefore represent CTR1-kd in its active 
and inactive conformation, respectively. Crystallization of CTR1-kd and CTR1-D676N 
yielded orthorhombic crystals of different subgroups, each with two molecules per 
asymmetric unit (Mayerhofer et al., 2011). Data collection statistics and refinement for all 
crystals are summarized in Table 8. 
Table 8: X-ray data-collection, processing and refinement statistics of the CTR1 kinase 
domain. Values in parentheses are for the highest resolution shell 
  CTR1-kd CTR1-D676N 
X-ray source ID23-2, ESRF ID29, ESRF 
Wavelength (Å) 0.8726 0.9763 
Resolution range (Å) 46.2-3.01 (3.18-3.01) 47.1-2.50 (2.64-2.50) 
Temperature (K) 100 100 
Crystal-to-detector distance (mm) 293.3 371.2 
Rotation range per image (°) 1.0 0.75 
Total rotation range (°) 70 220 
Space group P41212 P42212 
Unit-cell parameters (Å) a = b = 95.71, c = 179.78 a = b = 122.33, c = 95.01 
Observed reflections 93474 (14334) 334176 (52905) 
Unique reflections 17053 (2648) 47817 (7636) 
Multiplicity 5.5 (5.4) 13.1 (13.2) 
Rmerge (%) 17.6 (84.2) 9.0 (83.3) 
R pim (%) 8.5 (40.0) 2.7 (25.3) 
Completeness (%) 98.3 (97.4) 99.8 (98.9) 
<I/ (I)> 9.5 (1.8) 16.9 (2.4) 
Wilson B factor (Å
2
) 73 60 
Optical resolution (Å) 2.2 1.9 
Refinement   
Rwork / Rfree 20.1 / 25.6 19.5 / 23.2 
No. atoms   
    Protein 4286 3939 
    Ligand/ion 34 34 
    Water - 61 
B-factors   
    Protein 60 55 
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    Ligand/ion 73 71 
    Water - 46 
R.m.s. deviations   
    Bond lengths (Å) 0.002 0.01 
    Bond angles  0.54 0.96 
 
Structure of active CTR1-kd 
Despite the non-homogeneously phosphorylated sample, crystallization succeeded in 
the presence of staurosporine. Crystals diffracted x-ray radiation up to 3 Å resolution and 
they contained two independent copies of the kinase in the asymmetric unit. As expected, 
CTR1-kd adopts the characteristic protein kinase fold with a 5-stranded anti-parallel β-
sheet in the N-lobe (res. 540-626), including a characteristic -helix, and a larger, 
predominantly -helical C-lobe (res. 632-821). Both lobes are connected by a short linker 
(res. 627-631) (Figure 20). 
Figure 19: Thermofluor results of the CTR1 kinase domain in the presence of different 
nucleotides and staurosporine (STU). Every molecule was run as a duplicate. 
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Figure 20: Structure of the wild-type CTR1 kinase domain in cartoon representation. The 
broad range kinase inhibitor staurosporine is shown in sticks. The missing loop between 
3 and helix C is indicated by a dotted line. 
Both molecules show well-defined and continuous electron density with the exception 
of one short stretch in each copy. The P-loop of protomer B shows high B-factors and 
disconnected density at the tip of the loop from residues Gly560 to Gly563 in contrast to 
protomer A where the same stretch is well defined. Conversely, there is no electron 
density for the loop preceding helix C (res. 583 to 586) in protomer A, while the same 
region shows well-defined connectivity in protomer B. After several rounds of refinement 
and manual model building, electron difference maps showed positive density for 
staurosporine in the active site of protomer A. No ligand was added in the active site of 
protomer B due to the very weak electron density there. Apparently, the P-loop is very 
N-
lobe 
C-lobe 
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Figure 21: A MS result of CTR1 wild-type and a zoom of the region corresponding to the 
masses of the 3-6 fold phosphorylated CTR1-wt B Activation loop of CTR1 wild-type with 
electron density of residues 704-710 contoured at 1σ, shown in blue. Selected residues are 
shown as sticks 
3P 
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flexible in the absence of a ligand in the active site. It seems reasonable to assume that 
the natural interaction with ATP has a similar effect on the P-loop. 
In both copies of CTR1-kd the side chains of Thr704, Ser707 and Ser710, located in the 
activation loop, are clearly phosphorylated (Figure 21 B), as indicated by MSMS 
fingerprinting analyses. Despite the presence of alternatively phosphorylated species in 
the purified sample, no other phosphorylation sites were found in the structure of CTR1-
kd. Apparently, this fraction of the sample is sufficiently abundant and conformationally 
homogeneous for crystallization. 
Structure of inactive CTR1-kd 
In order to understand the principles, which govern the activation of CTR1-kd, we 
produced an enzymatically inactive version of the kinase by replacing a strictly conserved 
aspartate in the catalytic loop with asparagine (CTR1-D676N). The Asp676 serves as a 
general base in abstracting a proton from the hydroxyl group of the attacking substrate. 
The crystallographic structure of CTR1-D676N at 2.5 Å resolution reveals that the 
functionally important activation loop is completely unstructured. Disorder begins at Phe695 
of the DFG motif, which initiates the activation loop, and continues until about six residues 
upstream of the loop terminating APE motif (res. 697-712 of protomer A and res. 697-711 
of protomer B). Additional disorder exists in the loop of protomer B connecting strand β3 
and helix C as well as the N-terminus of helix C. The equivalent region in protomer A 
however, shows clear connectivity. This could, at least partially, be explained by a different 
surrounding in the crystal with this region in protomer B having no interaction partner as 
does protomer A. 
CTR1-D676N was also crystallized in the presence of staurosporine. As in CTR1-kd, 
the ligand is present in the active site of protomer A of CTR1-D676N while it is absent 
from protomer B. Again the absence of staurosporine is accompanied by significantly 
higher temperature factors of the P-loop, which is localized further towards the empty 
active site compared to protomer A whose active site is occupied. This increased flexibility 
of the P-loop is mirrored at the adjacent strand 3 and the loop connecting it with helix C. 
In contrast to CTR1-kd, there is no electron density for the entire loop and the amino 
terminus of helix C between residues 580 and 592 in ligand-free protomer B of the inactive 
mutant. In the inhibitor bound form of CTR1-D676N, these regions are well defined. This 
observation underlines the interdependence of structural integrity and active site 
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composition in CTR1. No phosphorylation sites were found in the structure of CTR1-D676N 
(Figure 22B). Mass spectrometry corroborates this and further proves that the structurally 
disordered activation loop of the kinase dead mutant is indeed un-phosphorylated. 
 
Figure 22: A Movement of helix C between the active (blue) and inactive (green) form of 
the CTR1 kinase. The comparison is based on an LSQ alignment of The C-terminal 
domains (res. 632 to 810) of CTR1-kd and CTR1-D676N. B MS result of inactive CTR1 
showing no phosphorylation. 
Dimerization 
Regulation of kinase activity through the formation of homo- and heterodimers is an 
established phenomenon. In particular, the ability of B-RAF to homodimerize and its in vivo 
activation through heterodimerization with KSR, a pseudo-kinase, has been demonstrated 
recently (Rajakulendran et al., 2009). Since active (Figure 25 A) and inactive (Figure 25 B) 
CTR1-kd form apparent homodimers in the crystal in different space groups across 
interfaces, which are virtually identical to those found in B-RAF (Figure 25 C) and RAF-1 
(Figure 25 D), the possibility of a similar mechanism was explored. In addition all the 
residues which play a crucial role in the dimerization of B-RAF (Rajakulendran et al., 2009) 
are conserved in CTR1 (Figure 23). Standard purification via size exclusion 
chromatography (SEC) indicated a monomer for CTR1-kd and CTR1-D676N rather than a 
dimer, with a calculated size of 40 kDa compared to the theoretical weight of 35 kDa. 
Analytical ultra-centrifugation, however, clearly showed a single peak with a maximum at 
63kDa for CTR1kd, which correlates well with twice the molecular weight of the monomer 
A B 
10 Å 
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of 35kDa (Figure 26 A). The dimer interfaces (Figure 24 A) observed in the crystal 
structures when calculated by PISA (Krissinel and Henrick, 2007) cover 1249 Å2 and 1072 
Å2 in CTR1-kd and CTR1-D676N, respectively. The interface residues are basically the 
same in both structures. The variance in surface area arises from small differences in the 
side chain orientations.  
There are several amino acids, which are conserved among the dimer interfaces of 
CTR1 (Figure 24 B), B-RAF and KSR. Arg604, Phe611 and Met612 (CTR1 numbering) were 
shown to be critical to the stability of the dimer interface in B-RAF and KSR by mutation 
(Rajakulendran et al., 2009). Initially three mutants were made, namely Arg604His, 
Phe611Ala and Met612Trp (M20 - M22), and purified similar to CTR1-kd. These residues are 
conserved among CTR1 proteins from various plants (Figure 23 blue stars). Mutations in 
CTR1-kd, equivalent to those found to monomerize B-RAF, resulted in the formation of 
predominantly monomers (Figure 26 A) as analysed by AUC. Interestingly when CTR1-
D676N was analysed by AUC it is also present mainly as a monomer (Figure 26 B), 
differing from the dimer observed in the crystal structure. The three interface mutants - 
despite being mainly monomeric - were found to be phosphorylated by MS implying that 
they are least partially active (see below).  
This supports the importance of the conserved residues on the formation of the 
interface. On the other hand there exists no simple correlation between the activity of 
CTR1 and the dimerization, at least when investigating the isolated kinase domain of CTR1 
(see next chapter).  
Three more mutants were designed and purified namely Arg604Ala (M23), Arg602Asp 
& Arg604Ala (M24) and FM611AW (M25). The additional Arg604Ala mutant was also designed 
as the initial Arg604His mutant, when modelled in the structure, could – depending on the 
actual side chain orientation of the histidine - still contribute a hydrogen bond to the main 
chain of Met600 or Leu603 of the dimer partner, which could affect the activity. Arg602 forms 
hydrogen bonds with Asp540, 543 and Asn669. Arg604Asp was designed to increase the 
repulsive forces between the two molecules. The FM611AW double mutant was made to 
test if the reduction in activity of the individual mutations is additive. Again, while all 
mutants are mainly monomeric, a small fraction was still present as a dimer (Figure 26 C, 
D and E) and again all of them showed some degree of phosphorylation. 
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Figure 23: Alignment of the kinase domains of CTR1 from A. thaliana, Oryza sativa, Cucumis melo, Populus trichocarpa, Vitis vinifera, 
Rosa hybrid cultivar, Malus x domestica, Prunus persica, human and mouse B-RAF and human KSR1. Mutated residues are indicated by 
stars below the amino acid. Red Glue626Lys, orange interface mutants and blue activation loop mutants 
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Figure 24: A Interface of CTR1-kd. Chain B shown with 
transparent surface, the activation loop shown in green, 
staurosporine in sticks B Zoom of the interface with the 
conserved, subsequently mutated residues shown as sticks. 
Chain A shown in blue, chain B in yellow. Staurosporine is 
omitted for clarity. 
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In order to test the effect of ATP onto dimerization the three mutants were run on an 
analytical S75 SEC column in the presence (1mM) and absence of ATP. While there was a 
clear difference in elution volume compared to the wild-type, confirming again the 
monomeric state, ATP had no influence on the oligomerization state. Therefor the 
observed continuous activity in the coupled assay of M20, M23 and M24 seems to be 
possible with >95% of the protein present as a monomer. 
As the unphosphorylated CTR1-D676N forms a monomer while the phosphorylated 
CR1-kd forms a dimer the effects of activation loop phosphorylation on the oligomeric 
state was tested. Two mutants were tested a double mutant of Thr704 and Ser707 to alanine 
and triple mutant adding the Ser710 to alanine mutant. Both were analysed by AUC and 
show a mix of monomer and dimers being present (Figure 26 F and G). 
The expression of the recently published mutant Glu626Lys (Ikeda et al., 2009) failed 
unfortunately and the effect on the dimerization could not be assessed. 
  
  
Figure 25: Cartoon and transparent surface representation of the molecules as observed 
in the crystal structures of A CTR1-kd B CTR1-D676N C B-Raf (pdb ID 3C4C) D RAF-1 
(pdb ID 3OMV). The individual chains are shown in blue and green  
A 
C D 
B 
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Figure 26: Analytical ultracentrifugation of the A CTR1 kinase domain and three interface 
mutants (Arg604His, Phe611Ala and Met612Trp) affecting dimerization, B of the CTR1 kinase 
dead mutant (CTR1-D676N) and the three additional mutants C Arg604Ala, D Arg602Asp & 
Arg604Ala and E FM611AW present predominantly in the monomeric state. Mutants of the 
activation loop F Thr704Ala and Ser707Ala and G with the additional Ser710Ala mutation 
show a mix of monomeric and dimeric protein 
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Activity of CTR1  
CTR1-kd is multiply and heterogeneously phosphorylated when expressed in and 
purified from E. coli. The attempts to produce a homogenously phosphorylated form of 
CTR1-kd in vitro, by incubating the protein with an excess of ATP overnight, were 
unsuccessful as shown by mass spectrometry. To further explore the relationship between 
structure and activity of CTR1 a coupled assay was employed, which records the 
consumption of NADH by lactate dehydrogenase (LDH) in the process of reducing 
pyruvate to lactate. The pyruvate is provided by pyruvate kinase (PK), using 
phosphoenolpyruvate (PEP) and ADP. The only source of ADP in this assay is CTR1 as long 
as it consumes ATP.  
The assay shows autophosphorylation activity of CTR1-kd. The Km-value for ATP, 
calculated by the coupled assay, is 50 µM (Table 9). This value is about 5-times higher 
than a previously published result of 9.1 µM when using BSA as substrate (Huang et al., 
2003). Our MS analyses, however, clearly show that CTR1-kd enters our activity assays in 
an already multiply phosphorylated state. This suggests that this CTR1-kd is in a dynamic 
equilibrium where one or several of the phosphorylated side chains of CTR1-kd are labile 
and undergo rapid hydrolysis or dephosphorylation as in the coupled assay the 
consumption of ATP by CTR1-kd is continuous. Even at a NADH concentration three orders 
of magnitude above the initial ATP concentration, the reaction continues until all of the 
NADH has been consumed. When the assay is resupplied with NADH, the reduction of 
pyruvate to lactate resumes. A equilibrium is also consistent with the inability to produce a 
homogeneously modified kinase by prolonged incubation of CTR1-kd with ATP. As 
expected, CTR1-D676N shows no activity confirming the crucial importance of Asp676 for 
protein kinase activity. 
Table 9: Km and kcat values for autophosphorylation of the CTR1 kinase domain and three 
interface mutants as determined using the coupled assay. 
 WT R604H F611A M612W 
Km (µM) 49,94 51,11 356,1 40,65 
kcat (min
-1) 65,91 63,27 4,15 26,91 
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As CTR1-kd was shown to be present as a dimer in solution by AUC a number of 
mutants targeting the interface (Arg604His, Phe611Ala, Met612Trp) were assessed for their 
effect on the catalytic activity. Surprisingly even though the mutants were clearly 
predominantly monomeric the influence on the activity was quite divergent (Table 9).  
The monomer inducing mutations had different effects on the activity of CTR1-kd in 
vitro. While one mutant (Arg604His) had basically no effect on the activity the two other 
mutants showed a more pronounced influence on the activity. While Met612Trp reduced the 
activity by approximately 50% the Phe611Ala mutant more or less completely abolished the 
activity (Figure 27, Table 9). This shows that the dimer interface has a big influence on the 
catalytic activity as measured in the coupled assay, even though it is located on the 
opposite site of the activation loop and the catalytic residues. Attempts to obtain the 
crystal structure of the inactive, monomeric mutants were so far unsuccessful.  
All mutants are mainly monomeric but still a small dimer fraction is present (Figure 26). 
Therefore additional mutations were tested in order to explore if double mutants could 
completely remove the observed dimer fraction. The three additional mutants Arg604His, 
RLR602DLA and FM611AW (M23-M25) were also assessed regarding their activity. While the 
Arg604Ala and RLR602DLA mutants did hardly affect the catalytic activity with a comparable 
activity to CTR1-kd, the M25 mutant was again showing no activity in this assay (Figure 
28).  
In the structure of CTR1-kd three residues were clearly phosphorylated. One of 
them, Ser710, is at a highly conserved position, termed the primary phosphorylation site in 
RD kinases. Interaction between the primary phosphoryl group and the basic pocket in 
CTR1-kd (Figure 34) structurally resembles the situation in the active forms of other RD 
kinase representatives from the AGC, CMGC and TK kinase families. An overlay of the C-
terminal domains from four AGC (pdb ID 1OL5, 1ATP, 1O6K, 1H1W), three CMGC (pdb ID 
1QMZ, 2ERK, 1CM8), and three TK (pdb ID 1IR3, 1K3A, 3LCK) family members and CTR1-
kd shows that the respective primary phosphates are on average within 1.8 Å ( = 0.9 Å), 
despite dissimilar lengths and conformations of their activation loops.  
Therefore the effects of removing the phosphorylation sites in the activation loop were 
explored. Four residues were chosen, the three observed in the crystal structure (Thr704, 
Ser707 and Ser710) and in addition Ser703 which was found by MS but not in the crystal 
structure. All four residues were mutated to alanine (M14) and, using this mutant, the 
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effect of individual replacement to glutamate, mimicking phosphorylation, was tested 
(M15-M18). All mutants abolished the continuous activity observed in the wild-type to the 
level of the kinase-dead mutant. None of the single glutamate substitutions could restore 
this activity (Figure 29). Nevertheless when being measured by MS all mutants were found 
to be phosphorylated. 
 
 
 
  
Figure 27: Catalytic activity of CTR1-kd and three single interface mutants 
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Figure 28: Activity of CTR1-kd and the three additional interface mutants Arg604Ala, 
RLR602DLA and FM611AW 
 
 
 
 
 
 
 
 
 
Figure 29: Activity measured by the coupled assay of the activation loop mutants M14-
M18 mutating four residues to alanine followed by individual replacements to glutamate, 
mimicking phosphorylation 
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Discussion 
The effects of ethylene have been utilized and observed for thousands of years 
starting from burning incense to enhance the ripening of fruits to the observation of early 
fruit ripening of plants growing close to gas street lamps. For more than hundred years 
(Neljubov, 1901) ethylene is known to cause the numerous known effects and since the 
mid-80s, with the first mutants of members involved in ethylene signalling, a complex 
network has be uncovered. A number of crucial proteins has been discovered enabling the 
transmission of the ethylene signal from the membrane-bound ethylene receptors and the 
prime interaction partner CTR1 to the transcription factors EIN3 and EIL1 in the nucleus 
(Stepanova and Alonso, 2009). Despite decades of research on ethylene signalling using 
genetic and biochemical techniques leading to well characterized ethylene receptors, 
structural information of the proteins involved remained incomplete, with only the 
structure of the ETR1 receiver domain being available (Müller-Dieckmann et al., 1999).  
The histidine kinase domain and the receiver domain, the latter not present in all 
receptors in A. thaliana, show similarity to the bacterial two-component system typically 
found in prokaryotes. On the other hand is the C-terminal kinase domain of CTR1, similar 
to RAF kinases which are classically the starting point of a MAPK pathway. Structures from 
prokaryotic HKD containing proteins also in complex with the receiver domain and also of 
the eucaroytic RAF family are available.  
In order to improve the knowledge of this interesting intersection of two different 
signal networks a number of domains and domain combinations were expressed and the 
structures of the ERS1 dimerization domain and the CTR1 kinase domain were determined 
to high resolution as well as the solution structure of the cytoplasmic domains from ETR1 
using SAXS.  
ERS1 dimerization domain 
HKs are involved in a number of reactions namely autokinase, phosphotransferase 
and phosphatase reactions and the dimerization domain plays a role in all of them. The 
different activities are often regulated by their N-terminal sensor domain and the signal is 
thought to be transmitted to the other domains through a rotation and tilting movement of 
the helices, leading to different conformations of the HKD. The dimerization domain of 
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ERS1 is so far the first described structure of this domain of eukaryotic origin and extends 
the observed N-terminal portion compared with prokaryotic structures. It reveals an 
organization similar to the available results from bacteria, with a dimer consisting of an N-
terminal parallel coiled-coil followed by a four-helix bundle. The observed, longer N-
terminal part furthermore allowed for a more reliable placement of the GAF domain in the 
model used for the cytosolic domains of the ethylene receptor. 
The original construct, based on bioinformatic domain prediction, needed to be 
extended by 18 residues at the N-terminus in order to obtain diffraction data to high 
resolution. The reason for this could be an improved and thereby stronger crystal contacts 
between the N-terminus of the now extended coiled-coil with the four-helix bundle in 
symmetry related molecules as exemplified by the different interaction interfaces. While in 
the determined structure this interface is about 400 Å (as calculated by PISA) it is reduced 
to 230 Å when artificially reducing the structure to the size of the initial construct H9. The 
N-terminal extension contributes a number of polar and apolar interactions in the crystal 
structure between symmetry related elements. Even though the interface is less than 1000 
Å in size, too small to be considered stable in solution, this difference can be enough to 
stabilize the crystal assuming a similar packing between the crystals. This modification 
also avoided or at least modified the packing observed in the initial construct H9, which 
possibly consisted of alternating layers in a hexagonal space group rotated by 30° with 
respect to each other, giving rise to the observed, interesting diffraction pattern (Figure 11 
B).  
Interface 
Coiled-coils are a relatively simple building block of proteins with the hallmark of a 
seven-residue heptad repeat with hydrophobic residues at position a and d forming a 
seam of knobs-into-holes interactions (Crick, 1953). The interface of the coiled-coil in 
ERS1 is not always following the classical heptads. There are also polar (Ser316, Gln326, 
Asn327) and charged residues (Arg320, Arg334) in the interface which are - with the 
exception of Ser316 - located at the d or e position of the heptad. Charged residues at 
positions a and d were also found in the HKs EnvZ or Sln1. The interface residues are 
conserved among the five ethylene receptors in A. thaliana. Out of 11 interface residues 
between residues 312 and 339 eight are completely conserved and two are conservatively 
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replaced and one (Ala319) is occupied by Met in subfamily 2 (Figure 11 A). This suggests a 
very similar interface in all five ethylene receptors. 
 
The coiled-coil in the yeast HK Sln1, was found to be needed for the dimer formation 
and normal activity (Tao et al., 2002). Recently also the structures of the DesK HK in three 
different activation states became available. There conformational signals are transmitted 
through interhelical rearrangements in the DHp domain modulating the positioning of the 
CA domain and the interaction with the receiver domain (Albanesi et al., 2009). This 
movement is accompanied by changes in the position and angle of the coiled-coil helices 
and rearrangements of the four-helix bundle exposing a hydrophobic patch, allowing for 
interactions with the CA domain leading to its change of position. Similar, in the structure 
of the isolated TM0853 HKD from T. maritima, the N-terminal coiled-coil is visible, while it 
is more twisted and disordered in the complex with the receiver domain.  
When comparing the structure of the ERS1 DHp domain with the three DesK HKDs 
the highest similarity is present with the structure in the phosphatase-competent state. 
There, as in ERS1, an N-terminal part is ordered and forms a coiled-coil. Conversely in the 
other conformations this part is not visible as the helices are disordered or show a very 
asymmetric conformation.  
Mutations in the C-terminus of the DHp domain were found to affect phosphatase 
activity, while not changing kinase activity (Hsing et al., 1998). These residues, when 
mapped on the structure of the T. maritima HKD, are central in the interface with the CA 
domain. When comparing this region of the ERS1 and ETR1 DHp domains with bacterial 
structures, the residues interacting with the CA domain are conserved (ERS1 residues 
Asp401, Leu405 and Glu406 and Leu450, Ala453, Leu454, Arg459 and Gln462 in the CA domain). In 
the ERS1 DHp domain they are positioned such that they are accessible for an interaction 
with the CA domain, arguing for a similar positioning of the CA domain as observed in 
phosphatase-competent bacterial structures. While actual phosphatase activity is not likely 
in ERS1 due to the lack of a receiver domain this gives some indication that a similar 
interaction and binding between the DHp and CA domain also exists in eukaryotes. 
When the sequences of the linkers between the two helices in the four-helix bundle 
of the five receptors in A. thaliana are compared, they appear to fall into two groups. The 
linkers of subfamily 1 (ETR1 and ERS1) have nearly identical linker sequence (only ERS1 
Ser375 exchanged for ETR1 Thr375 in the six residues linker), while the linker sequences of 
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subfamily 2 are diverse (Figure 11 A). The topology in the ETR1 dimerization domain will 
probably be quite similar to the situation in ERS1, also as the sequence identity between 
the two dimerization domains in subfamily 1 is very high (84%), while no prediction of the 
connectivity between the helices can be made for subfamily 2. Given these differences it is 
possible that the connectivity is different in subfamily 2, which could allow for a cis-
phosphorylation mechanism. 
An interesting feature of the dimerization domain of ERS1 is the different bending 
angle between helix A1 and A2 observed within the dimer. This difference can be observed 
in two different space groups, C2221 and P21212, and between the two dimers per AU in 
P21212. While the r.m.s.d. between equivalent C atoms between the protomers of similar 
conformation is 1 Å, it increases to 2 Å for those of a different conformation. This is true 
for the comparison within dimers or across space groups. The observed difference of 9° of 
the kink within dimers is therefore consistent and unlikely to be accidental. As a 
consequence, the dimerization domain of ERS1 is asymmetric (Figure 30) and this 
asymmetry would also be found in the N-terminal GAF domains and possibly all the way 
into the membrane domain. Because this part of the receptor was also shown to be 
involved in binding of CTR1, the conformational difference may indicate one way of 
communication between signal binding domain and the cytosolic output domains.  
 
Figure 30: Superimposition of the two helices in the ERS1 dimerization domain from 
residue 351 to 404. Helix A is shown in green, helix B is shown in blue. 
The structure of the entire cytoplasmic portion of the T. maritima HK TM0853 is 
available as well as structural information of the DesK and KinB HKs and of the 
dimerization domain of EnvZ. Superimposition with the EnvZ DHp domain does not yield a 
9° 
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very good fit caused by the partly disordered nature of EnvZ whose structure was 
determined in solution by NMR. EnvZ exhibits an unusual orientation angle between 
neighbouring helices different from those previously determined as being favourable (Chou 
et al., 1988). The DHp domain of ERS1 exhibits the more stable angle similar to the HKD 
of TM0853 from T. maritima. With the remaining structures the four-helix bundle 
superimposes well but shows more divergence in the coiled-coil region probably reflecting 
the different conformation that can be adopted depending on the signal. The hairpin 
connection topology in the four-helix bundle is different from those found in TM0853, 
DesK or KinB but similar to the situation in EnvZ, stressing again this surprising variability 
between different histidine kinases.  
When using the structure from T. maritima (pdb ID: 3DGE) as model the catalytic 
domain comes close to the conserved histidine residue of the second protomer in the 
dimer, which suggests a trans-phosphorylation mechanism frequently observed in histidine 
kinases. A heterodimer of the full HK domain of ERS1 with a construct comprising only of 
the DHp domain was purified, which can serve as the starting point to elucidate the mode 
of phosphorylation. 
ETR1 full cytoplasmic portion  
As no crystals of the cytoplasmic domains of ETR1 could be obtained, a construct, 
excluding only the membrane-spanning part of ETR1, was analysed by SAXS.  
The overall SAXS parameters determined from the scattering data suggest that the 
cytoplasmic domains of ETR1, construct H46, predominantly exist as dimers (calculated 
MM 130 kDa) in solution under the conditions used in this study.  Yet the obtained value of 
MMSAXS (Table 7) is low compared with the calculated value of a dimer. Accurate 
concentration estimation was problematic for this sample (discrepancy between two 
methods) in the presence of the solubilizing agent NDSB, impacting upon the 
normalisation of the SAXS intensities and as a result under or over estimating I(0) (and 
thus MMSAXS). Therefore MMSAXS was considered to be an unreliable parameter (being 
dependent on accurate sample concentration for normalisation of the scattering 
intensities). More accurate estimates of the MM were obtained from the parameters 
describing the hydrated particle volume, VolSAXS (directly obtained from the SAXS curve) 
and VolDAM (determined from the ab initio bead models constructed from the SAXS data) 
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(Table 7). The concentration independent estimates for VolSAXS and VolDAM are higher than 
expected for a monomeric H46, being more in line with a dimer (expected volume for 
dimeric H46, based upon a molecular weight of ~ 130 kDa, is 208 nm3 for VolSAXS and 260 
nm3 for VolDAM). The hydrated particle volume VolSAXS (282 nm
3) is consistent with that 
expected for a dimeric H46, however, VolDAM (165 nm
3) is significantly lower, suggesting 
that some monomeric H46 is also present in an equilibrium with dimeric H46. As the 
solubilizing agent NDSB is likely to interact with the surface of H46 and also contribute to 
background scattering it is probable that it has had some effect on the estimation of the 
particle volume. However, taking this into account it remains clear that H46 can form 
dimers in solution. 
To help resolve the ambiguity of the monomer – dimer question for H46 a simple 
modeling approach was conducted.  Using the ab initio shape envelope reconstructed from 
the SAXS data it is possible to manually fit all the high-resolution structures of the 
domains in this volume as a dimer, supporting that all the domains are indeed present in 
the measured sample. Rigid body modelling using the high-resolution structures of the 
domains and a homology model of the GAF domain also provides strong evidence that the 
sample contains predominantly intact H46 dimers, due to the excellent fit of the resulting 
H46 models to the data at low angles (< 2-3 nm-1). The quality of the fit deteriorates at 
higher angles due to the strong background signal from the 250 mM NDSB, however, the 
SAXS data in this range is essentially featureless and not required for low-resolution 
modelling of the dimer.  
The overall dumbbell shape obtained by ab initio modelling correlates well with the 
constructed dimeric model (Figure 16B). The GAF domain is positioned at the top of a 
central helical bundle with the catalytic domain of the HK and the receiver domain at the 
other end. There seems to be some flexibility of the receiver domain position (Figure 17 C) 
but the position is distinct from the one described for a T. maritima receiver domain in 
complex with its HK (Casino et al., 2009) as expected by the length of the linker between 
the CA and the receiver domain. In the two obtained models the receiver domain is not in 
a position compatible with a phosphotransferase-competent state. Unfortunately the SAXS 
data of the cytoplasmic domains of ETR1 is of too low resolution to assign a functional 
state. In the two obtained models the active site of the receiver domain is pointing away 
from the conserved histidine residue in the dimerization domain. Positioning of the 
aspartate in the receiver domain for phosphoryl-transfer would require a rotation of the 
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receiver domain relative to the dimerization domain as well as a small translation. This 
would highly stretch the linker between the domains therefore a movement of the CA 
domain as observed in the structures of DesK or TM0853 would also be required.  
  ETR1 HK activity was demonstrated to have a role in growth recovery after removal 
of ethylene (Binder et al., 2004b) and in regulation of growth (Qu and Schaller, 2004). In 
addition genomic ETR1 could rescue a slow growth recovery phenotype, while a mutant 
replacing the conserved Asp659 in the receiver domain could not. This underlines the role 
of the receiver domain in this process and the contribution of a TCS-like signalling pathway 
in the ethylene response. Given the functional role of the receiver domain changes of its 
position are likely to be possible and to occur. The interface between the CA domain of the 
HKD and the receiver domain alone does not seem to be very strong as SEC of the 
isolated domains did not indicate complex formation and also SAXS analysis of a construct 
comprising only the catalytic and the receiver domain suggest an extended conformation 
(results of S. Panneerselvam). Hence, also as shown by the two different positions in the 
SAXS models of the receiver domain, it seems to occupy a number of positions in solution 
in the absence of other signals.  
The here presented SAXS model gives the first impression of the overall composition 
of the cytoplasmic domains of an ethylene receptor in one state, yet leaving structural 
changes upon signals and protein interactions open. 
CTR1 kinase domain 
Since the first structural description of a kinase, the cyclic adenosine 
monophosphate-dependent protein kinase (Knighton et al., 1991), many more examples 
followed. The conserved motifs and numerous regulation mechanisms have been revealed 
and still every kinase offers a somewhat different picture regarding its regulation, cellular 
location or substrate recognition, which allows it to distinguish itself from the hundreds of 
other kinases found in higher eukaryotes reflecting their different tasks.  
Structure comparison 
The most conspicuous structural difference between active and inactive CTR1-kd is 
the conformation of the activation loop. This loop is stabilized through phosphoryl group 
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mediated interaction with the rest of the enzyme. In the absence of these phosphoryl 
groups the activation loop is disordered.  
Superposition of the structures of active and inactive forms of CTR1-kd revealed 
further differences. Helix C of the N-terminal lobe assumes two distinct orientations 
(Figure 22A). A phosphorylated and structured activation loop causes the N-terminal part 
of helix C to tip towards the C-terminal lobe, moving by more than 7 Å. This movement 
conforms to a rotation of helix C about a pivot perpendicular to the helical axis and 
through its C-terminus. The amount of rotation corresponds to about 11° based on the 
alignment of the C-lobes (res. 632 to 810) of CTR1-kd and CTR1-D676N. The immediate 
consequence of this helix movement is a tighter conformation of the kinase. In CTR1-
D676N, the open form of the kinase, the conserved salt bridge between Lys578 in 3 and 
Glu596 in helix C is disrupted and 6.1 Å apart in the better defined protomer A. Lys578 is 
fundamental in the productive orientation of the alpha and beta phosphates of ATP. 
Consequently, the active site of the open conformation of CTR1-kd would be expected to 
be incompetent to bind ATP productively, based on the relative position of Lys578 (Hanks & 
Hunter, 1995). In the closed form, however, Lys578 and Glu596 interact at distances of 2.8 Å 
and 3.0 Å in the two protomers in the AU. Additionally, the DFG motif of the active form 
assumes an Asp-out conformation with Asp694 forming a hydrogen bond with the backbone 
amide of Gly696. In the inactive, open form the DFG motives in both protomers are very 
poorly defined and the glycine residues are disordered. 
 
When comparing CTR1-kd with the active conformation of PKA (pdb code 1ATP) it is 
obvious that the amino acids needed for phosphorylation activity are correctly positioned. 
The Asp676 of the HRD motif interacts with the side chain of Asn681 (Figure 31) allowing it 
to orientate the attacking hydroxyl from the substrate. The P+1 loop is anchored to the 
hydrophobic core through interactions of Trp717 with Val739 and Ile740 in helix F, which are 
themselves part of a hydrophobic network, similar to the situation found in PKA (Yang et 
al., 2004). This anchor is supported by the interaction of Glu721 with Arg795, which packs 
against Tyr735 in helix F. This creates a link to the catalytic loop through the hydrogen bond 
formed by Asp733 to the backbone amides of His674 and Arg675 as well as the hydrogen 
bonds of Glu743 in helix F with Trp717 and Ser679.  
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Activation loop phosphorylation causes the catalytic loop segment to move by up to 2 
Å and thereby enables several conserved interactions. The conserved Thr714 at the 
beginning of the P+1 loop interacts with Asp676 which has been suggested to help lock the 
aspartate in the conformation needed for the interaction with the hydroxyl of the substrate 
(Figure 31). Thr714 in CTR1-D676N, located right after the disordered region, moves about 
3.5 Å away from Asp676, thereby abandoning the interaction. Thr714 in CTR1-kd interacts 
also with Lys678 another highly conserved residue in the catalytic loop (Figure 31). The 
anchoring of the P+1 loop (with Thr714 at its beginning) is conserved in most protein 
kinases and seems to be important for the substrate recognition and activity (Nolen et al., 
2004). The P+1 loop interacts with the substrate but is also directly or indirectly 
connected to the catalytic loop allowing it to sense the presence of substrate.  
 
Figure 31: Overlay of the active site of CTR1-kd (yellow) and CTR1-D676N (grey). 
Selected residues are shown as sticks with the interactions show as black, dashed lines. 
Only the start and the end of the kinase dead activation loop are shown as it is mainly 
disordered. Parts of the structures were omitted for clarity. 
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The crystal structure of active CTR1-kd revealed three phosphorylation sites, all of 
them located in the activation loop. A triple alanine mutant Thr704Ala, Ser707Ala and 
Ser710Ala demonstrated the prerequisite of activation loop phosphorylation for the 
observed CTR1 activity in the coupled assay (Figure 29) with the activity of this mutant 
being comparable to that of kinase dead CTR1-D676N. Still some phosphorylation was 
detected by MS showing the phosphorylation is not absolutely crucial for activity 
(discussed later) yet the biological role of these sites is unclear. Phosphorylation confers 
structure to the activation loop, which is disordered in inactive and un-phosphorylated 
CTR1-D676N. Structuring of the activation loop triggers several conformational 
rearrangements, which are typically found in the active forms of protein kinases. One 
example is the formation of a short but essential anti-parallel -sheet between 6 
(Pro671/Ile672/Val673), which precedes the catalytic loop, and strand 9 
(Arg699/Leu700/Lys701) within the activation loop and. Formation of this -sheet is initiated 
through the recruitment of Arg675 and Arg699 to the so-called basic pocket, which 
assembles around phosphoserine 710 (SEP710). Arg675 is part of the catalytic loop HRD 
motif, which succeeds strand 6. When compared with the inactive CTR1-D676N the C of 
Arg675 moves 1.9 Å towards the activation loop. In this conformation, the side chain of 
Arg675 also forms a hydrogen bond with the backbone carbonyl of Leu697, which is located 
directly after the loop initiating DFG motif, further stabilizing the activation loop. 
Recruitment of Arg699 triggers the formation of strand 9, which is disordered in the 
inactive mutant (Figure 31).  
The salient feature of the phosphorylated activation loop consists of the electrostatic 
interface between SEP710 and the previously described basic pocket. This interaction likely 
precedes and therefore triggers the described structural rearrangements. Since neither of 
the other two activation loop phosphoresidues, phosphothreonine 704 and phosphoserine 
707, directly participate in any interactions (cut-off 3.5 Å), SEP710 will be referred to as the 
primary phosphorylation site and CTR1 as an RD kinase as defined in a 2004 review 
(Nolen et al., 2004). Interaction between the primary phosphoryl group and the basic 
pocket in CTR1-kd structurally resembles the situation in the active forms of other RD 
kinase representatives from the AGC, CMGC and TK kinase families. An overlay of the C-
terminal domains from showed that the respective primary phosphates are on average 
within 1.8 Å ( = 0.9 Å), despite dissimilar lengths and conformations of their activation 
loops. In addition to the aforementioned canonical Arg675 and Arg699 a third basic residue, 
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Arg595 from helix C, comes to within 4 Å of SEP710 and augments the basic pocket in CTR1. 
Employment of Arg595 probably contributes to the movement and/or stabilization of helix 
C, which was discussed earlier. Interactions from basic residues located in the helix C have 
also been described for other Ser/Thr kinases (Krupa et al., 2004). 
During the MS analysis a number of additional phosphorylation sites were found not 
observed in the structure. Yet similar observations have been reported for residues 
determined to be phosphorylated by MS, which were found unphosphorylated in the 
structure (Knowles et al., 2006), (McTigue et al., 1999). The most probable explanation for 
this observation is that only a sub-fraction of molecules being sufficiently abundant is 
forming the crystal. 
Mode of staurosporine binding 
Crystallization trials in the presence of AMPPNP resulted in no crystals. In a 
thermofluor assay staurosporine improved the thermal stability considerably while for all 
nucleotides tested smaller effects were observed. In both structures staurosporine is 
bound in the large groove between the lobes by hydrogen bonds (Glu626, Leu628 and 
Pro680) and CH–π interactions, with the plane structure of the staurosporine being 
sandwiched by hydrophobic residues (Figure 32). The binding of the ligand between the 
two structures is very similar. When compared with the Lck, Fyn and Lyn kinases in 
complex with staurosporine (pdb ID: 1QPD, 2DQ7, 3A4O), the position of the 
staurosporine and its interactions are highly conserved. Even though in both CTR1 
structures magnesium was present in the crystallization buffer, no obvious density for an 
ion could be observed.  
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Activity and Dimerization of the CTR1 kinase domain 
Despite the extensive research targeted at B-RAF the presence and importance of 
dimerization by the enzyme was not recognized until recently (Rajakulendran et al., 2009). 
When the side-to-side dimer interface was disturbed by specific mutations most of the 
substrate phosphorylation was lost. Interestingly CTR1 crystallized in the active and 
inactive state in a very similar dimeric arrangement as exhibited by B-RAF (Figure 25).  
The interface residues found to be crucial in B-RAF dimerization are also present in 
the RAF-related pseudo-kinase KSR, which can interact with and activate B-RAF. These 
residues are conserved in CTR1 (Figure 23). After the initial verification of CTR1-kd being 
a dimer in solution, confirming the crystal structure, the role of these conserved residues 
was investigated. All of them play a role in formation of the in vitro dimer in solution as 
already single mutations at these three positions (Arg604, Phe611 and Met612) lead to the 
formation of predominantly monomers. Yet mutations of the positions Arg604Ala, Arg602Asp 
& Arg604Ala and FM611AW could not completely abolish the observed small dimer fraction. 
This is probably due to equilibrium between the states and despite disturbing the interface 
some interaction is still possible. Probably other residues involved provide a still strong 
enough interface allowing for transient binding. The activity is partially affected by these 
Figure 32: Staurosporine bound to CTR1-kd. The electron density for staurosporine is 
shown in grey at 1σ. Residues around the ligand are shown in sticks. Polar interactions 
are indicated as black dashed lines 
E626 
L683 
V565 
I557 
L628 R635 
P680 
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mutations with some mutations (Met612Trp, FM611AW) causing the loss of the continuous 
activity observed in the wild type. Also in B-Raf kinase the mutants had varying effects on 
the activity (Rajakulendran et al., 2009). All of the CTR1 mutants also retained some of 
the autophosphorylation activity. Some off the residues found to be involved in the 
interface (Arg602, Arg604) are part of a basic patch and a similar motif was shown in Raf-1 
to be important for binding to the inhibitor phosphatidic acid (PA) (Ghosh et al., 2003). 
While the same residues don’t play a role in PA binding in a mutant a reduction of the 
kinase activity was also observed (Testerink et al., 2007). 
Remarkably in the crystal structure CTR1-D676N is forming the same dimer interface 
as does the wild-type, yet in solution it was present as a monomer. No obvious structural 
changes of the interacting residues can be observed when aligning the interfaces of CTR1-
kd and CTR1-D676N. Also the mutated residue Asn676 and the biggest conformational 
changes found in N-terminus of helix C and the activation loop are not part of the 
interface, making it difficult to determine the exact reason for the monomeric form. The 
high protein concentration in the crystal could allow CTR1-D676N to overcome the weak 
affinity preventing dimerization in solution and to form a dimer, similar to the wild-type.  
When analysing the effects of mutants of the activation loop a mix of dimers and 
monomers (Figure 26 F and G) was observed highlighting the contribution of activation 
loop phosphorylation to the dimerization. Phosphorylation is compacting the structure 
through the rotation of N-lobe, which pivots by 7.4° towards its C-lobe in CTR1-kd, 
possibly stabilizing the dimer through subtle changes. This also allowed assigning a role to 
phosphorylated Thr704 and Ser707, which in the structure seem to have no role in 
stabilization compared to Ser710, but are needed to shift the equilibrium to the dimer in 
solution. A double mutant of Thr704 and Ser707 to alanine already causes the shift to a 
dimer/monomer mixture when compared with the wild type. Addition of the Ser710Ala 
mutant does not change this shift or enhance it. This is in line with preliminary results of a 
low resolution structure (3.25 Å) of the Thr704 and Ser707 mutant being more similar to the 
CTR1-D676N structure than the CTR1-kd one. Therefore even in the absence of a clear 
role in activation loop stabilization they contribute to the structural integrity and are 
needed for dimerization.  
Mutants of the three observed phosphorylation sites in the activation loop are still 
phosphorylated to some extent outside the activation loop. This must be due to 
autophosphorylation as CTR1-D676N was found to be completely unphosphorylated. This 
D i s c u s s i o n  -  P a g e  | 106 
 
was relatively unexpected, as phosphorylation of the activation loop is often triggering 
activity in RD kinases. Even the primary phosphorylation site Ser710, which is highly 
conserved in position when comparing with other kinases where it often plays a pivotal 
role during activation of the kinase, is not crucial for auto-phosphorylation activity in vitro. 
Moreover CTR1 exhibits a continuous consumption of NADH in the coupled assay in the 
absence of a substrate. The simple explanation is it being a rapid hydrolysis of one 
residue, which gets subsequently again phosphorylated therefore leading to an 
unproductive circle. Yet this explanation clashes to some extend with Ser/Thr 
phosphorylation normally known to be relatively stable. Mutations in the activation loop 
and some affecting the dimerization can stop this phenomenon making it unfortunately 
difficult to assign specific crucial residues.  
Also in other Ser/Thr kinases a varying number of phosphorylation sites in the same 
batch were reported (Young et al., 2003). Yet as in CTR1 only phosphorylation of the 
activation loop was consistently observed and connected with a clear role. In CTR1 the 
remaining sites are scattered throughout the molecule and only observed in fractions of 
the proteins and are possibly an artefact of the high concentration of the protein in the cell 
and the expression in the absence of the N-terminal domain. 
In a recent structure of the M. tuberculosis Ser/Thr Kinase PknB bound to an ATP-
competitive inhibitor an asymmetric dimer was observed interacting via the helix G 
(Mieczkowski et al., 2008). One molecule possesses an ordered activation loop (suggested 
as the active conformation), while the other has a disordered activation loop (inactive 
conformation) with the ends pointing to the active site of the active molecule. This was 
suggested to be the activation complex with a front-to-front association allowing for the 
trans-phosphorylation and the activation of the kinase (Mieczkowski et al., 2008). 
Mutations in the helix G were sufficient to abolish kinase activation. In both CTR1 
structures a similar interaction via the helix G of symmetry related molecules can be 
observed with similar interface sizes. Yet the interaction is different as chain B of the 
CTR1-D676N front-to-front interface is rotated about 30° and translated slightly relative to 
chain B of the CTR1-kd front-to-front interface when superimposing the C-lobes of chain A 
of the two structures. When using this superimposition a hybrid front-to-front model can 
be created, consisting of the active chain A (CTR1-kd) and the inactive chain B (CTR1-
D676N), interacting through helix G. There the C-terminal, structured end of the activation 
loop on CTR1-D676N points to the active site of the active wild-type structure similar to 
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the situation in the PknB structure. The first structured residue in the inactive structure 
Gly713 is about 13 Å away from the active site in the wild-type molecule. Therefore in this 
conformation Ser707 and the primary phosphorylation site Ser710 of the inactive molecule 
could be phosphorylated by an active kinase in a different dimer (Figure 33) in a similar 
fashion as in PknB, leading to its activation. Due to steric restraints phosphorylation of 
Thr704 would probably require a different conformation. This would allow for a cross-
receptor signal transmission, allowing one active dimer to phosphorylate a number of 
neighbouring, inactive dimers (see next section). 
 
Figure 33: Hybrid model of an inactive CTR1-D676N molecule shown in sand interacting 
via helix G with an active CTR1-kd protomer shown in blue. The disordered activation loop 
(dashed brown line) is positioned at the entrance of the active site of the CTR1-kd 
molecule with Asp676 shown in sticks. The ordered activation loop is shown in green; both 
helixes G are shown in brown and dark blue, respectively. 
In general all mutated interface and activation loop residues and the residues in helix 
G are highly conserved when comparing with other CTR1 molecules from other species 
(Figure 23). This suggests that the results obtained for CTR1 from A. thaliana are very 
likely to be also valid for other plants and mutants will have similar effects the dimerization 
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and phosphorylation patterns. The residues involved in dimerization of the kinase domain 
are also conserved in human and mouse B-RAF and KSR1 underlining the importance of 
the dimerization for the function, allowing for the evolutionary conservation. In contrast 
the activation loop is, not unexpectedly, quite diverse when comparing human and plant 
kinases, reflecting their different cellular roles. 
 
The loss of dimerization shifts the kinase to some extend to the inactive state 
showing reduced activity. Furthermore the activity is not only depending on activation loop 
phosphorylation in vitro and the presence of the substrate ATP does not affect 
dimerization. CTR1 is initially present as an unphosphorylated monomer, yet able to 
autophosphorylate to some extent supporting the formation of a stable dimer. This leads 
to a gradual shift of the kinase from the inactive to the active state with all parts 
contributing but none being the only decisive element making the on/off decision.  
 
 
Dimerization has an influence on the activity of CTR1 which is, given the results from 
the AUC and the highly conserved interface residue, very likely to act as a dimer in vivo. A 
S710 
R595 
R675 
R699 
Figure 34: Superimposition 
of the basic pocket of CTR1-
wt (yellow) and CTR1-D676N 
(grey) with the 
phosphorylated serine and 
the three arginines shown as 
sticks. Ser710 and Arg699 are 
disordered in CTR1-D676N  
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recently identified mutant of CTR1 was found to affect planar polarity of roothair 
placement in A. thaliana, exhibiting a Glu626Lys amino acid exchange located at the loop 
connecting the N-lobe with the C-lobe. The highly conserved side chain is pointing towards 
the dimer interface and the substitution with lysine could lead to repulsion and subsequent 
destruction of the dimer. A reduction of the in vitro kinase activity was observed and an 
increase of auxin biosynthesis (Ikeda et al., 2009). This gives some indication of the 
physiological role of dimerization, with the mutant only partially affecting the activity, while 
still being able to block the cellular role. Unfortunately this mutant could not be purified 
despite testing different tags and media, preventing the assessment of the mutation on 
the dimerization. 
All this supports CTR1 as a very active kinase which needs to be strongly inhibited in 
order to allow the ethylene signal to proceed to the nucleus. As CTR1 autophosphorylates 
in the absence of activating molecules, one can speculate that CTR1 is structurally flexible 
in the absence of phosphorylation, with a fraction being in a phosphorylation-competent 
state, being able to interact with other kinases allowing for their phosphorylation. 
Implications for signal transduction 
A consequence of the specific dimer interface of CTR1 is a positioning of the 
expected substrate binding sites (close to the P+1 loop and Asp676) on opposite sides of 
the kinase dimer being over 40 Å apart (Figure 24 A). This excludes the possibility of an 
intra-dimer, trans-autophosphorylation mechanism. Also the large distance of more than 
24 Å between the hydroxyl side chain of phosphorylated Thr704 in the activation loop and 
the catalytic Asp676 in the same molecule makes it difficult to imagine a cis-
phosphorylation mechanism. In addition cis-phosphorylation in Ser/Thr kinases is a rare 
event, which needs special biochemical properties and often an interaction with another 
protein in order to overcome the steric problems, keeping it from occurring more 
frequently (Lochhead, 2009). Trans-phosphorylation across CTR1 dimers is further 
supported by the presence of an activation interface via helix G, which closely resembles 
the complex recently described for PknB (Mieczkowski et al., 2008) and the orientation of 
the disordered activation loop (Figure 33). Modelling of a complex of CTR1-kd by 
substituting an active monomer within the observed packing via helix G of CTR1-kd with 
inactive CTR1-D676N, positions the open ends of the disordered activation loop pointing 
into the active site of active CTR1-kd. The distance between the C-atom of the first 
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visible residue after the strand break, G713, and the side chain of catalytic D676 is 12Å, 
which corresponds to three amino acid residues in an extended polypeptide chain. This 
would position the active site catalytic base in immediate contact with the hydroxyl group 
of the primary phosphorylation site of CTR1 (Ser710), as required for deprotonation. 
 
The ethylene receptors and CTR1 are active in the absence of ethylene. In addition 
CTR1 was now found to be a very active kinase and, when expressed without its N-
terminal part, being able to self-activate in the absence of other molecules. Furthermore a 
number of mutants targeting the activation loop and the dimerization interface could not 
completely abolish the activity when assessed by MS. This suggests a very active enzyme 
effectively blocking the pathway in the absence of ethylene. The exact mode of CTR1 
deactivation is still unknown. Phosphatidic acid was shown to bind to the kinase domain 
and deactivate CTR1 as well as the interaction with ETR1 and the N-terminal domain. 
Various biotic and abiotic stresses, also associated with ethylene signalling, are known to 
lead to the PA synthesis and PA was suggested to be at the start of ethylene signalling 
acting when ethylene is still absent (Testerink et al., 2008). Also a change in the 
interaction with the ethylene receptors caused by structural rearrangements resulting from 
the ethylene binding is a probable mechanism affecting the kinase activity, the 
phosphorylation state, the dimerization or interactions with the substrate(s) of CTR1. 
Regardless of the exact way of regulation it appears that a strong deactivation signal is 
needed in order to overcome the robust activity of CTR1.  
The ethylene receptors are known to form dimers and also associations with other 
receptor dimers were shown (Gao et al., 2008). In addition the receptors can respond to 
ethylene at a concentration 300-fold lower than the Kd of the receptors for ethylene. This 
suggests that the ethylene receptors form clusters similar to the situation found in bacteria 
(Gestwicki et al., 2000), leading to a local increase of the signalling molecules being able 
to signal in a cooperative manner. With the here presented evidence for dimerization in 
CTR1 in vitro, similar to the RAF kinases, and the presented model of cross-dimer 
phosphorylation this adds another level of interaction between molecules. Two possible 
modes of binding to the receptors can be envisioned: A dimer of CTR1 molecules binds to 
a homodimer of ethylene receptors (Figure 35) or a dimer of CTR1 molecules binds to two 
different ethylene receptor dimers. While the first model would support the homodimer 
stability the second could promote the predicted cluster formation through the linkage of 
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receptor homodimers. In addition both models allow one active CTR1 molecule to 
phosphorylate other surrounding molecules (Figure 33) and possibly also other substrates. 
CTR1 mediated inter-receptor communication may therefore rapidly spread across 
receptors clusters and multiply the output signal from a single ethylene molecule. The 
combination of dimer and activation interfaces, as revealed by the crystal packing of 
CTR1-kd, results in a continuous head-to-tail oligomer of kinase dimers (Figure 35). 
 
Figure 35: A model of 
cross-receptor signalling. An 
active CTR1 dimer (shown in 
grey) binds to one ethylene 
receptor dimer and is able 
to phosphorylate other 
inactive CTR1 molecules 
(blue) and allow for signal 
transduction between 
different receptors being in 
different activation states. 
 
CTR1 plays a central role helping to integrate a number of different inputs leading to 
the choice of the appropriate response. The role of dimerization and phosphorylation with 
the connected autophosphorylation activity represent one aspect of the CTR1 regulation. 
Some other factors, as phosphatidic acid, which seems to play a role at the beginning of 
the ethylene response, the phosphatase PP2A, which was shown to be important for the 
activity of CTR1 or the Glu626Lys mutant, which was found to influence the auxin 
biosynthesis, highlight the complexity of the signalling network surrounding CTR1. 
Therefore further testing, especially in vivo, of the here presented insights into the 
structure, biochemistry and oligomeric state of CTR1 will be needed to gain an in depth 
understanding of this part of the ethylene signalling network and to be able to understand 
the wealth of processes regulated. 
A 
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ACC  1-aminocyclopropane-1- 
 carboxylic acid 
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 2 
AU Asymmetric unit 
AUC Analytical ultra-centrifugation 
-ME β-Mercaptoethanol 
CTR1  Constitutive triple response 1 
CA Catalytic and ATP-binding 
  domain 
CTR1-kd CTR1 kinase domain (wild- 
 type construct) 
CTR1-D676N CTR1 kinase dead  
 mutant  
CV Column volume 
DHp Dimerization and histidine 
 phosphotransfer domain 
EIL  EIN3-like 
EIN2  Ethylene insensitive2 
EIN4 Ethylene insensitive 4 
ER  Endoplasmic reticulum 
EREBP  Ethylene response element  
 binding protein 
ERF1  Ethylene response factor 1 
ERS   Ethylene response sensor  
ETR Ethylene receptor 
GMO Genetically modified organism 
HK Histidine kinase 
HKD Histidine kinase domain 
IC3 5-amino-2,4,6- 
 triiodoisophthalic acid 
IPTG Isopropyl β-D-1- 
 thiogalactopyranoside 
(k)Da (kilo)Dalton 
LOF Loss of function 
MAPK  Mitogen activated protein  
 kinase 
MAPKK  MAPK kinase 
MAPKKK  MAPK kinase kinase 
MR Molecular replacement 
MS Mass spectrometry 
NDSB Non-detergent sulfo betaine 
NiNTA Nickel-nitriloacetic acid 
PA Phosphatidic acid 
RAN1 Responsive to antagonist 1 
R.m.s. Root-mean-square 
SCF Skp, Cullin, F-box containing  
 complex 
SEC Size exclusion chromatography 
SER Surface entropy reduction 
SOC Super Optimal Broth 
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Appendix 
The methods for the mass spectrometry analysis carried out by the staff of the EMBL 
Core facility are summarized below. 
In-solution digestion 
All reagents used were dissolved in 50 mM ammonium bicarbonate.  Approximately 
100 µg of protein was taken (50 µL of a 2 µg/ µL solution provided) and diluted to 1 µg/µL 
in 50 mM ammonium bicarbonate.  Proteins were then reduced (2.5 µL of 50 mM DTT, 56 
°C, 30 minutes) and alkylated (110 mM iodoacetamide, 2.5 µL, room temperature, in the 
dark, 20 minutes).  Trypsin digestion (1 µL of a 1 µg/µL solution) was carried out 
overnight at 37 °C. 
LC-MS/MS 
Peptides were separated using the Proxeon Easynano LC system (Thermo Fisher) 
fitted with a trapping column (self-packed Hydro-RP C18 (Phenomenex), 100 µm x 2.5 cm, 
4 µm) and an analytical column (self-packed Reprosil C18 (Dr. Maisch) 75 µm x 15 cm, 3 
µm, 100 Å).  The outlet of the analytical column was coupled directly to an HCT Ultra Ion 
Trap mass spectrometer (Bruker Daltonics) using the ESI nanoflow source in positive ion 
mode.  
Solvent A was water, 0.1 % formic acid and solvent B was acetonitrile, 0.1 % formic 
acid. The samples (8 µL) were loaded with a constant pressure (280 bar) of solvent A with 
a total volume of 15 µL onto the trapping column.   Peptides were eluted via the analytical 
column a constant flow of 0.3 µL/min. During the elution step, the percentage of solvent B 
increased in a linear fashion from 4 % to 40 % B in 20 minutes.   
On the HCT Ultra, a spray voltage of 4.3 kV was applied. The drying temperature 
was set at 200 °C, with drying gas at 6 L/min and nebulizer gas at 7 psi. Data was 
acquired in standard enhanced mode.  Full scan MS spectra with mass range 350-1500 
m/z were acquired in profile mode with a maximum fill time of 200 ms or 200000 counts. 
MS/MS was performed in an automated fashion on the 3 most intense ions from the full 
scan MS.  MS/MS spectra were also acquired in profile mode over the mass range 100 – 
2000 m/z.  Dynamic exclusion was used after 2 MS/MS events and had a maximum period 
of 30 seconds. 
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Data analysis 
Software scripts within Hystar (Bruker) were used for creating .mgf files, needed for 
searching in MASCOT version 2.2.03 (Matrix Science). The data were searched against a 
species specific (arabadopsis thaliana) swissprot database as well as a list of common 
contaminants. The data were searched with the following modifications: Carbamidomethyl 
(C) (Fixed) and Oxidation (M) (Variable), Phosphorylation (ST).  The mass error tolerance 
for the full scan MS spectra was set at 0.3 Da and for the MS/MS spectra at 0.3 Da. A 
maximum of 1 missed cleavage was allowed. Only peptides with Mascot score above 20 
were reported. 
Intact Protein Sample Preparation 
Prior to analysis, protein samples in solution were zip-tipped using C4 ZipTips 
(Millipore).  Conditioning and equilibration of the ZipTip for sample binding was performed 
(3 aspirations each time) with 50:50 water:acetonitrile, followed by water, 0.1% TFA. 
Proteins were bound to the ZipTip by aspiration of the protein solution 10 times.  The 
sample was then washed using water, 0.1% (5 times).  Proteins were eluted in 10 µL of 
50:50 water:acetonitrile, 1% formic acid.  Eluant was aspirated 3 times for good sample 
recovery. 
Intact Protein Sample Analysis 
Salt-free samples were loaded into coated (3AP) borosilicate PicoTip Emitters (New 
Objective) and mounted on the static nanospray source of a Q-Tof II mass spectrometer 
(Waters/Micromass).  After breaking the needle tip, 1.8 kV was applied to the PicoTip.  A 
cone voltage of 40 V was used, with extraction cone at 10 V.  A collision energy of 8 eV 
was used, with Argon in the collision cell.  Data were acquired in continuum mode 
between 500 and 3000 m/z with a 1 second scan time and acquired for approximately 1 
minute.  Data were externally calibrated against a reference standard of intact myoglobin, 
acquired immediately prior to sample data acquisition.  Spectra were then summed and 
intact mass was calculated using the MaxEnt1 maximum entropy algorithm 
(Waters/Micromass) to give the zero charge deconvoluted molecular weight.   
 
 
